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CHAPTER I 
 
INTRODUCTION 
 
 Neuropsychiatric disorders such as generalized anxiety disorder, panic disorder, 
post-traumatic stress disorder, and depression all involve disruptions in emotional 
regulation. These disruptions encompass not only disturbances in mood and anxiety, but 
also disturbances in the physiological response to stress (Chrousos & Gold, 1992; Mello, 
Mello, Carpenter, & Price, 2003; Rosen & Schulkin, 1998). These behavioral and 
physiological alterations are correlated with dysfunctions in the limbic circuitry of the 
brain, but the underlying neural causes are complex and there is no evidence for gross 
defects in the brain. Instead, reported central nervous system (CNS) alterations are 
multiple and subtle (Millan, 2003). The origins of complex neuropsychiatric disorders 
such as anxiety disorders and depression are also not well understood. However, it has 
become apparent through both human and animal investigations that their etiologies are 
developmental, dependent upon complex interactions of genes and environment (Gross & 
Hen, 2004; Leonardo & Hen, 2008). 
 To improve the treatment and outcome of disorders of emotional regulation it is 
necessary to better understand both the changes in brain signaling that underlie the 
behavioral and physiological components of the disorders and the origin of those 
changes. One way to tackle these questions is by using animal models to investigate the 
neural basis of anxiety behaviors and the stress response, using either environmental or 
genetic perturbations to disrupt emotional regulation. In this chapter I review the current 
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state of knowledge about emotional regulation in animal models from a behavioral, 
neurobiological and developmental perspective. I introduce a specific example of a 
developmentally relevant protein from a class of molecules whose roles in emotional 
regulation are, thus far, infrequently considered. 
 
The Stress Response 
 In order to define the response to stress, it is first necessary to define stress itself. 
Here, stress is defined as any challenge to homeostasis (maintaining the internal 
environment in a constant state). When homeostasis is challenged an animal mounts both 
a hormonal and autonomic response. Challenges to homeostasis are not always marked 
by threat (the prototypical “flight-or fight” response). A stress response is mounted to any 
number of “stressors”, including environmental challenges that might not be considered 
threatening, such as exposure of an animal to another of the opposite sex (Marchlewska-
Koj & Zacharczuk-Kakietek, 1990), birth (Liggins, 1994), suckling (Uribe, Redondo, 
Charli, & Joseph-Bravo, 1993), and feeding (Rovirosa, Levine, Gordon, & Caba, 2005). 
Stress responses are also mounted to potentially dangerous or harmful stimuli such as 
novelty (Grootendorst, de Kloet, Dalm, & Oitzl, 2001; Rodgers et al., 1999), social defeat 
(Buwalda et al., 1999), cold stress (Bligh-Tynan, Bhagwat, & Castonguay, 1993), and 
immune challenge (Mekaouche et al., 1996). 
 There are two main legs to the physiological response to stress, autonomic and 
endocrine. The autonomic response is immediate and is primarily mediated by the 
release, from the sympathetic nervous system (SNS), of epinephrine into the bloodstream. 
This causes an increase in heart rate, blood pressure and a number of other cardiac 
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functions as well affecting brain function (for review of the SNS role in stress see: 
Wortsman, 2002; Wurtman, 2002). The endocrine response is slower, longer lasting and 
has been greatly studied for its role in behavior, disease and emotional regulation. The 
neuroendocrine response will be the focus of this chapter.  
 A cascade of three hormones from the hypothalamic-pituitary-adrenal (HPA) axis 
is responsible for producing the neuroendocrine stress response (Figure 1). The response 
begins with the release of corticotropin releasing hormone (CRH) from the para-
ventricular nucleus of the hypothalamus (PVN) into the portal bloodstream to the anterior 
pituitary. CRH stimulates the release of adreno-corticotropin hormone (ACTH) from the 
pituitary into the peripheral bloodstream. ACTH acts on the adrenal medulla to excite the 
release of Corticosterone (CORT). CORT release is basally regulated on a circadian 
cycle, with the highest levels of circulating CORT during the active period (night for 
rodents) and the lowest levels at the beginning of the rest period (day for rodents). In 
response to stress CORT release is greatly up regulated. The surge of CORT into the 
peripheral bloodstream begins to occur within minutes, generally peaks within half an 
hour and has numerous effects including altering metabolism to release glucose stores 
and working in concert with the SNS response to alter heart rate and blood flow (Miller 
& O'Callaghan, 2002). CORT feedback to the brain turns off the stress response by acting 
at a number of structures including the hippocampus, the PVN and the pituitary (Herman, 
Ostrander, Mueller, & Figueiredo, 2005). The magnitude and duration of CORT stress 
response varies in proportion with intensity of the stressor (Campeau & Watson, 1997) 
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Figure 1. The hypothalamic-pituitary-adrenal axis. 
(Adapted from Tilbrook & Clarke, 2006). 
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and pathological states are frequently associated with increased HPA reactivity to stress 
or disturbances in normal feedback (Chrousos & Gold, 1992). 
 The effects of CORT in the brain are mediated through two known receptors, the 
mineralcorticoid receptor (MR) and the glucocorticoid receptor (GR) (Reul & de Kloet, 
1985, 1986). GRs are more widely distributed than MRs and, because of their much 
lower affinity for CORT, are considered to be the mediators of negative feedback in the 
brain (de Kloet, Karst, & Joels, 2008; Reul & de Kloet, 1985, 1986). MRs, on the other 
hand are involved in regulating basal levels of CORT. Traditionally both GRs and MRs 
are considered to be nuclear receptors—binding of CORT causes translocation to the 
nucleus, where the receptors can alter transcription (de Kloet et al., 2008; Joels, 2006). 
This mode of signaling allows them to have prototypical slow effects: modulating basal 
CORT levels for MR and shutting CORT off after stress, which can take hours, for GR. 
However, there is accumulating evidence that there are fast effects of CORT in the brain. 
Membrane bound MR receptors have been identified as having non-genomic effects in 
the hippocampus (Karst et al., 2005) and there is evidence of fast-feedback in the 
amygdala, hypothalamus and pituitary as well (Dallman, 2005). The ability of CORT to 
mediate fast, non-genomic effects in the brain has implications not only for neuronal 
signaling (Joels, Karst, DeRijk, & de Kloet, 2008; Karst et al., 2005), but also for 
behavior: there are examples of acute increases of CORT increasing behaviors such as 
aggression and locomotion within minutes (Haller, Halasz, Makara, & Kruk, 1998; Joels 
et al., 2008). 
 The development of the HPA axis and stress response is well-defined (Levine, 
2005; Meaney et al., 1993; Meaney et al., 1996; Rosenfeld, Suchecki, & Levine, 1992), 
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and there are critical periods in development during which alterations in the peri-natal 
environment can alter the adult HPA axis response to stress. Newborn rodents already 
have the ability to mount a CORT response to stress, but experience a stress-
hyporesponsive period (SHRP) early postnatally (post-natal days 4-14 in a rat) during 
which they cannot normally mount a CORT response to stress (Schapiro, Geller, & 
Eiduson, 1962; Schmidt, Enthoven et al., 2003). The SHRP is mediated by licking and 
grooming of the pups by the damand, separating the pups from the dam for 24 hours can 
disinhibit the dampening of CORT responsiveness (Levine, Stanton, & Gutierrez, 1988; 
Stanton, Gutierrez, & Levine, 1988) and alter responsiveness throughout the life of the 
offspring, indicating the importance of maternal care in mediating a sensitive period for 
adult functioning of the HPA axis. Meaney and colleagues have demonstrated that even 
slight variations in the quality of maternal care during a critical period (post-natal days 1-
7) that overlaps with the SHRP can have deleterious effects on the response to stress by 
the offspring when they are adults (Liu et al., 1997), with the offspring of dams that give 
lower quality care (low licker-groomers) having more reactive HPA axes as adults. In 
addition, as discussed in the following sections, the changes caused by this environmental 
alteration are accompanied by changes both in the behavioral response to stress and in the 
circuits that mediate the stress response.  
   
Stress-Related Behaviors 
 Generally, when measuring the behavioral response to stress in a rodent, the goal 
is to mimic or better understand the way that some manipulation (environmental or 
genetic) may be relevant to human behavioral states after stress. It is from this goal that 
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measuring “anxiety” in rodents has become universal. In an attempt to describe anxiety in 
a way applicable to both humans and rodents, Leonardo and Hen recently defined anxiety 
as “a state of cognitive and behavioral preparedness that an organism mobilizes in 
response to a future or distant potential threat” (Leonardo & Hen, 2008). There are many 
tests used to measure “anxiety” in rodents. These tests fall into two main categories: 
those that use conditioned response (e.g. fear-potentiated startle, shock probe burying) 
and those that instead rely on spontaneous behavior to determine the state of the animal 
(Rodgers, 1997). Tests of anxiety should ideally meet three measures of validity 
(predictive, face, and construct). The most commonly used tests of anxiety were 
developed for, and therefore have, predictive validity of the ability of anxiolytics (most 
notably Diazepam) to reduce anxiety in humans. Many of these tests also have face 
validity; that is, they appear to be measuring anxiety-like behaviors to an untrained eye. 
However, it is not apparent that they are necessarily models with construct validity (the 
basis of the elicited behavior is the same as that trying to be modeled) (Rodgers & Dalvi, 
1997). Generally, those behavioral tests that rely on spontaneous behavior (and 
exploration of a novel environment— certainly a “stressor”) are considered more 
ecologically valid (that is they are measuring responses that are more natural and are 
more likely to have construct validity) and I will utilize an example of one of these to 
discuss the measurement of anxiety behavior in more depth. 
 The elevated plus maze (EPM), like almost all other commonly used anxiety-
related behavioral tasks, relies on an approach-avoidance conflict (Crawley, 2008) and 
was developed to test the effects of anxiolytic drugs in rats (Pellow & File, 1986). The 
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Figure 2. The elevated plus maze. 
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maze is shaped like a cross with two enclosed arms and two open arms that form narrow 
platforms (Figure 2). The enclosed arms are considered more safe and the open arms 
more threatening, thus a rodent’s desire to explore a novel area is counteracted by the 
danger and fear evoked by an unenclosed space. Originally, the measures of interest were 
time spent in the open arms and closed arms and the number of entries in the open arms 
and closed arms. Rodents generally show a strong aversion to the “anxiety provoking” 
open arms and spend a greater amount of time and make a greater number of entries into 
the closed arms (Hogg, 1996; Pellow & File, 1986; Rodgers, 1997).  Anxiolytic 
Benzodiazapines increase the preference of rodents for the open arms as measured by 
both duration and number of entries (Pellow & File, 1986). 
 In an effort to increase the ecological validity of the test, other behaviors that take 
place during maze exploration have been defined (Rodgers, 1997). These behaviors 
include stretch-attend postures and head-dipping, two measures of risk-assessment. 
Several factor analyses of EPM behaviors have suggested that these two behaviors load 
with traditional measures of anxiety, but are inversely correlated with open time and 
entries (Cruz, Frei, & Graeff, 1994; Rodgers & Johnson, 1995), supporting the idea that 
risk assessment is increased in response to threat (Rodgers, 1997). Using these measures 
of ethologically relevant defense behaviors should increase the construct validity of 
exploratory tests, as clinical anxiety states in humans have been proposed to be 
inappropriately activated defense responses (Rodgers, 1997). 
 It is important to note that the behaviors elicited by the EPM and similar 
approach-avoidance tests (open field, light/dark, zero maze, open field emergence) are 
driven by the balance between behavioral/motor activation (needed in order to explore) 
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and behavioral/motor inhibition (needed to inhibit entry in potentially threatening parts of 
the maze). Generally, animals with greater “anxiety” (elicited by a drug, or genetic or 
environmental manipulation) will show more behavioral inhibition, and less exploration, 
whereas those with less anxiety will show greater behavioral activation (more 
exploration). To account for the complication of using motor behavior to measure anxiety 
state, an overall change in motor behaviors, i.e. hyper-activity, is normally measured by 
using behaviors that are not typically thought to fluxuate with anxiety state, such as the 
number of closed entries on the EPM (Rodgers, 1997). Even given the similarities in 
these tests and controls for motor activation, anxiety may be detected on one test and not 
another in the same animal. However, when interpreting the results of any exploration 
based “anxiety” test it is important to remember that validity is based on pharmacological 
manipulations and that the meaning of the exploratory/motor driven behaviors on the 
maze should be interpreted in the context of other behaviors (risk-assessment, freezing, 
etc) in order to best interpret the basis of the behavior with the most validity. 
 Not surprisingly, exposure to novel environments in the form of behavioral tests 
of anxiety, such as EPM, induces a neuroendocrine response (Matzel et al., 2006; Pellow, 
Chopin, File, & Briley, 1985; Qin & Smith, 2008). As is the case of many human anxiety 
disorders (Chrousos & Gold, 1992; Rosen & Schulkin, 1998), animals that demonstrate 
increased “anxiety” also often have increased HPA reactivity. This is seen with 
manipulations of both environmental (Liu et al., 1997; Stankevicius, Rodrigues-Costa, 
Camilo Florio, & Palermo-Neto, 2008) and genetic components (Koster et al., 1999; 
Raber et al., 2000). The converse is also true; rodents that demonstrate decreases in 
“anxiety” often have a correspondingly blunted HPA axis response to stress (Bale et al., 
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2002; Timpl et al., 1998). The behavioral and physiological phenotype is not just a 
correlational relationship. Acute injections of physiological levels of CORT cause an 
increase in anxiety-like behavior on the EPM (Mitra & Sapolsky, 2008), indicating that 
increases in CORT can mediate increased anxiety-like behavior. 
 Human anxiety disorders are now considered to be developmental in their origins 
(Leonardo & Hen, 2008) and, just as HPA axis reactivity is sensitive to developmental 
perturbations, so are anxiety behaviors. Maternal separation during the SHRP can induce 
long-term upregulation of HPA axis reactivity (Plotsky & Meaney, 1993), and it also 
effects long-term increases in anxiety-like behavior (Romeo et al., 2003). For example, 
the offspring of high licking/grooming rats not only display decreased HPA axis 
reactivity, but also demonstrate reduced anxiety behaviors on a number of tests. The 
offspring of high licking-grooming rats demonstrate both reduced HPA axis reactivity as 
adults, and decreased anxiety-like responding in several behavioral paradigms (Caldji, 
Francis, Sharma, Plotsky, & Meaney, 2000; Caldji et al., 1998). The developmental 
effects appear to be mediated by altering methylation state of the gene encoding GR, 
resulting in altered levels of GRs in the hippocampus (Weaver et al., 2004). Greater 
expression (less methylation) is more effective in mediating the negative feedback 
response to shut down the HPA axis response. These examples demonstrate that there is a 
clear relationship between emotional regulation and the neuroendocrine stress response in 
adults, and that they are developmentally linked, such that perturbations during critical 
periods of their development cause long-term alterations in function. To understand why 
the behavioral and endocrine stress responses are intertwined and to begin to investigate 
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how they are altered in pathological states, it is necessary to explore the neurobiology 
that coordinates and activates both behavioral and the endocrine responses to stress. 
  
The Circuitry of Emotional Regulation 
 Is there a neuronal circuit for emotional regulation? Broca described a set of 
structures he named “the limbic lobe” in 1878 (Broca, 1878) and in 1937, Papez 
employed many of those structures and published “A Proposed Mechanism of Emotion” 
in which he proposed that an inter-connected set of structures were responsible for 
emotion and emotional expression (Papez, 1937). Included in the “Papez loop” were the 
circuits that interconnect the cingulate cortex, the hippocampus, anterior thalamic nuclei, 
and the hypothalamus (along with “connecting structures” such as the mammilary bodies 
and cingulum). Ten years later, MacLean furthered the description of the brain circuitry 
involved in emotional mechanisms, describing what would become known as the limbic 
system, including Papez’s loop and adding other structures such as the frontal lobes and 
the amygdala (MacLean, 1949). Today a pubmed search with the words “limbic system” 
returns over 10,000 results, including nearly 1,500 reviews. However, there is no single 
agreed upon definition of what comprises the limbic system, and the structures included, 
ranging from cortical areas to brain stem nuclei have varied over time.  A number of 
researchers have suggested that there is no limbic system (Dalgleish, 2004; Heimer & 
Van Hoesen, 2006; Pessoa, 2008). One argument for this view is that each area included 
is involved in several functions and therefore not “primarily” responsible for emotional 
regulation (Pessoa, 2008). A counter-argument could be made that emotional regulation 
is so important to survival and, therefore, so intertwined with the performance of other 
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functions, such as memory and cognition, that it’s no surprise at all that it’s circuitry is 
involved in mediating such actions. There is abounding physiological, anatomical and 
molecular evidence that an interconnected set of brain structures are integral for defining 
emotional regulation and these structures are capable of mediating both the behavioral 
and endocrine response to stress (Charney & Deutch, 1996; Herman et al., 2005; Levitt, 
1984; Petrovich, Canteras, & Swanson, 2001). For the purposes of this discussion, I will 
continue to use limbic to suggest an interconnected set of structures that include both the 
historical limbic lobe, and also interconnected circuitry (to be introduced) that has a well-
defined role in behavioral, endocrine, and autonomic emotional regulation. 
 Parvocelluar neurons of the PVN are responsible for releasing CRH into the portal 
blood stream (Whitnall, 1993). These neurons receive direct inputs from many 
hypothalamic, sub-cortical and brainstem nuclei (e.g. bed nucleus stria terminalis 
(BNST), dorsal medial and lateral hypothalamus, pre-optic area, raphe nucleus, sub-
fornical organ) which are involved in regulating autonomic function, allowing the HPA 
to make a rapid response to homeostatic threats of an immune or physiological nature 
(Herman et al., 2003). Many of the areas of the brain that are responsible for mediating 
the HPA axis response to psychological threat (the limbic structures and circuitry) do not 
project directly to the PVN, but instead influence parvocellular neurons by indirect 
connections (Herman et al., 2003) (figure 3). In the following sections, I will concentrate 
on three main limbic structures, the amygdala, the hippocampus and the pre-frontal 
cortex and their circuitry to the parvocellular neurons.  
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Figure 3. Inputs to the PVN of the hypothalamus. 
(Adapted from Herman et al., 2003). 
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 The amygdala plays a central role in mediating autonomic, endocrine and 
behavioral responses to stress through reciprocal connections with thalamus, sensory 
cortices, brainstem structures, orbitofrontal cortex, hippocampus, BNST and 
hypothalamus (Charney & Deutch, 1996; Herman et al., 2003). The central nucleus 
(CeA) of the amygdala excites the HPA axis through connections with the lateral group 
of the BNST, which has glutamatergic (excitatory) projections to the PVN (Dong, 
Petrovich, & Swanson, 2001). The CeA also projects directly to the lateral hypothalamic 
area where it influences the autonomic response to stress. Finally, CRH-containing 
neurons project from CeA to the locus coeruleus (LC), a major source of norepinephrine 
(NE) in the brain, which itself is a major mediator of stress responsiveness (Morilak et 
al., 2005). The medial nucleus of the amygdala (MeA) projects to the transverse and 
interfascicular nuclei of the BNST; however, both of these connections appear to be 
largely GABAergic and therefore, may be excitatory to the PVN via disinhibition (Dong 
et al., 2001; Herman et al., 2003). There are amygdalar projections to the peri-PVN, 
which in turn has a significant GABAergic input to the PVN (Sawchenko & Swanson, 
1983). Finally, the lateral nucleus (LA) of the amygdala has projections through the 
hippocampus which indirectly influences hypothalamic nuclei involved in coordinating 
defensive behavior, such as the anterior nucleus (Petrovich et al., 2001). 
 The hippocampal formation (including dentate gyrus and subiculum) is also 
interconnected with sensory cortices, cingulate cortex, the BNST, and the hypothalamus 
(Herman et al., 2003). It is an important part of the circuit of negative feedback to shut 
down the HPA axis response (Feldman & Weidenfeld, 1999). These inhibitory actions 
are most likely mediated through the subiculum’s projections to several areas including 
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the BNST, peri-PVN, and other hypothalamic areas that relay to the PVN itself (Herman 
et al., 2003; Sawchenko & Swanson, 1983). There are also sparse projections of neurons 
from CA1 to the PVN itself (Cenquizca & Swanson, 2006). 
 The medial prefrontal (mPFC) cortex also is implicated in negative feedback of 
the HPA axis (Diorio, Viau, & Meaney, 1993; Herman et al., 2003). However, it is 
involved in the HPA axis response to stress as well, with evidence for both excitatory and 
inhibitory functions. This is due to the roles of multiple areas of mPFC in modulating the 
stress response. Lesioning of dorsal mPFC (pre-limbic) suggests that it inhibits PVN 
neurons, while ventral mPFC lesions (including infralimbic cortex (IL)) excite those 
neurons during stress (J. J. Radley, Arias, & Sawchenko, 2006). The mPFC also does not 
directly project to the PVN. Pre-limbic mPFC contains projections to pre-optic area and 
the peri-PVN, both inhibitors of the stress response. Alternatively, IL mPFC has 
connections with anterior BNST, lateral hypothalamus, MeA and CeA of the amygdala, 
all implicated in excitation of the PVN (Herman et al., 2005).  mPFC also has reciprocal 
connections with LC and it has been recently demonstrated that at least part of the 
excitatory effect of NE on HPA axis reactivity is mediated through mPFC (J. J.  Radley, 
Williams, & Sawchenko, 2008). 
 The circuitry involved in the behavioral response to stress completely overlaps 
with that discussed as involved in HPA axis reactivity. Partially, this is due CORT’s 
ability to directly affect behavior (see The Stress Response section above). However, the 
limbic circuitry as a whole is involved in mediating all aspects of emotional regulation, 
including behavioral, autonomic and neuroendocrine (Charney & Deutch, 1996). As 
would be expected of any circuitry regulating complex functions, the brain structures 
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involved are numerous (Figure 4); in order to functionally modulate anxiety or fear states 
the ciruitry must include sensory areas for the detection of threats, integrative areas, and 
output areas to elicit the physiological and behavioral response. This discussion will 
focus on a few key structures that are involved in integrating input and coordinating all 
aspects of the stress response. Charney and Deutch provide a comprehensive review of 
these structures and some of their major connections (Charney & Deutch, 1996). As 
mentioned above, the amygdala is central to emotional regulation due to its mostly 
reciprocal connections with cortical areas, the hippocampus, LC, the periaqueductal gray 
(PAG) and the hypothalamus (Figure 4). The CeA sends projections to several brainstem 
nuclei and has an excitatory effect on NE producing neurons of LC, as well as on nuclei 
regulating cardiovascular and respiratory control. BLA sends projections to striatum, 
situating it to modulate reward and motoric output. Stimulation of the amygdala in 
humans provokes feelings of fear and lesions in animals reduce fear related behaviors 
along with aggression. The mPFC also receives and sends projections to the amygdala, 
and to striatum. As with neuroendocrine stress responsiveness, the mPFC can both 
increase and decrease behavioral reactivity to stress. Ventromedial PFC (in a pre-limbic 
area) seems to function to decrease anxiety-like behavior in some situations, while IL 
increases anxiety-like responses in others (Wall, Blanchard, Yang, & Blanchard, 2004). 
Besides its role in the HPA axis, the hippocampus is important in consolidating memory 
associated with emotional events (for review see- (Phelps, 2004)) and therefore, is likely 
part of a circuit important in attaching salience to stress and possibly altering subsequent 
behavioral responses. The LC is connected with the circuitry of emotional regulation in 
several ways (see above) and is considered a direct activator of the HPA axis. Drugs that 
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Figure 4. The circuitry of emotional regulation. 
(Adapted from Charney & Deutch, 1996). 
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 increase the output of NE from the LC cause increased fear behavior in rodents and 
increased feelings of anxiety in humans.  
 These structures (amygdala, mPFC, hippocampus, LC, and hypothalamus) form 
the circuits that play a major role in all aspects of emotional regulation across mammalian 
species. Disrupting these circuits by modification of neurotransmitter function is 
common. There are many neurotransmitters that modulate the effects of stress, but there 
are a small number of molecules mentioned above that are important in mediating stress 
responsiveness and that have also been demonstrated to play a role in the development of 
the stress response. CRH is not only expressed by neurons in the PVN, but is also used as 
a neurotransmitter throughout the rest of the brain (one major site of release is the 
amygdala CeA). Alterations of the CRH system by genetically deleting the CRH receptor 
1 (CRHR1) have demonstrated its importance in regulating adult responsiveness to stress 
and anxiety (Muller, Keck, Zimmermann, Holsboer, & Wurst, 2000; Muller et al., 2003; 
Timpl et al., 1998), and also in modulating the activity of the HPA axis during the 
developmental sensitive period (SHRP) that is responsible for setting up adult 
responsiveness to stressors (Schmidt, Oitzl et al., 2003). NE has long been known to have 
an activating effect on the HPA axis and to be involved in anxiety-like behaviors 
(Morilak et al., 2005). Again, genetic deletion of the adrenergic alpha-2 receptor is 
associated with increased anxiety in adults (Lahdesmaki et al., 2002) and reduction 
specifically during the early post-natal critical period resulted in decreased anxiety along 
with increased expression of the receptor in adult animals (Shishkina, Kalinina, & 
Dygalo, 2004). Serotonin (5-HT) released from the raphe and other brainstem nuclei is 
another neurotransmitter that has been demonstrated to be both a modulator in emotional 
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regulation and to have involvement in human neuropsychological disorders (Kusserow et 
al., 2004; Leonardo & Hen, 2008). In addition, as with the other modulators of emotional 
regulation that have been discussed, disrupting 5-HT signaling through receptor knockout 
specifically during the critical period for developing stress responsiveness resulted in 
more anxious animals—developmental regulation of the neuromodulator was enough to 
change the animal’s stress response throughout it’s life (Gross et al., 2002).   
 The major excitatory and inhibitory neurotransmitters in the brain, glutamate and 
GABA, respectively, are very important in the circuits of stress responsiveness. Many of 
the excitatory projections to the PVN are glutamatergic (Figure 3) but glutamate is often 
missing from lists of genes important in anxiety or stress (Gratacos et al., 2007; Muller & 
Keck, 2002; Wood & Toth, 2001) because disruptions of glutamatergic signaling causes 
major changes in all parts of the brain and makes interpretation of phenotypes difficult. 
However, there are several examples of specific disruptions in glutamatergic signaling 
effecting emotional regulation (Alt et al., 2007; Du et al., 2008; Kiryk et al., 2008) and 
drugs that alter glutamtergic signaling through metabatropic receptors are being pursued 
as possible treatments for anxiety and depression (Palucha & Pilc, 2007).  
 The role of GABA in both anxiety-like behavior and the neuroendocrine response 
to stress is better characterized. Disturbances of the GABAA receptor system have been 
implicated extensively in clinical studies of depression and anxiety (for review see- 
(Brambilla, Perez, Barale, Schettini, & Soares, 2003; Nutt & Malizia, 2001)) and the 
most commonly prescribed anxiolytics for anxiety disorders are benzodiazepines 
((McLaughlin, Geissler, & Wan, 2003)), agonists to the benzodiazepine (BZ) receptors 
(i.e. GABAA receptors with subunits composing BZ sites). Decreased sensitivity to BZs 
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and decreased levels of BZ binding have been reported in the brains of patients with 
panic disorder and generalized anxiety disorder (Abadie et al., 1999; Kaschka, Feistel, & 
Ebert, 1995; Malizia et al., 1998; P. Roy-Byrne, Wingerson, Radant, Greenblatt, & 
Cowley, 1996; P. P. Roy-Byrne, Cowley, Greenblatt, Shader, & Hommer, 1990; 
Tiihonen et al., 1997) suggesting that alterations in BZ receptors may be a causative 
mechanism underlying anxiety disorders in humans. There also is evidence from animal 
studies that GABAA receptor levels and composition are related to the stress response and 
its development.  
 For example, in the maternal care paradigm of Meaney and colleagues, offspring 
of high licking-grooming mothers display reduced anxiety and HPA axis reactivity as 
adults. In addition offspring exhibit increased BZ binding in limbic areas that modulate 
the stress response, including amygdala nuclei (CeA, BLA, and LA), LC, and nucleus 
tractus solitarius (NTS) (Caldji et al., 2000; Caldji et al., 1998). The modified BZ binding 
in these animals is accompanied by permanent changes in the subunit composition of the 
GABAA receptors in the same structures. Levels of the 1, 1 and 2 GABAA receptor 
subunits are significantly increased in the CeA, BLA, LA and LC (1 and 2 only) of 
adult offspring of high L-G rats (Caldji, Diorio, & Meaney, 2003). The  subunits are 
required for formation of the BZ binding site and  subunits determine the affinity of 
different benzodiazepines for the receptor and the sensitivity of the receptor to GABA 
(for review of GABAA receptors see- (Macdonald & Olsen, 1994)). Inclusion of the 1 
subunit creates the BZ receptor subtype 1, which has a heightened affinity for certain BZ 
site ligands ((Macdonald & Olsen, 1994)). These changes in adult subunit composition 
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and BZ binding in the offspring of high licker-groomer mothers are due to alterations in 
the development of the system during an early postnatal critical period. 
 The demonstration that alterations of limbic circuit development can result in 
altered emotional regulation manifests the idea that the development of the circuitry 
itself, the anatomical connections between relevant structures, should play an important 
role in the development of the stress response. Alterations in molecules that regulate 
circuit formation, such as cell adhesion molecules (CAMs), are interesting candidates for 
examining the role of circuit formation on emotional regulation. Guidance molecules are 
responsible for facilitating appropriate connectivity in forebrain circuitry during 
development through a combination of attractive and repulsive cues (for review see - 
(Lopez-Bendito & Molnar, 2003)).  Cell adhesion molecules (CAM’s) of the 
immunoglobulin super-family (IgSF) are guidance molecules with multiple functions 
including neurite outgrowth, axon guidance, and synapse formation (Rougon & Hobert, 
2003). There is evidence that genetic disruption of a widely expressed CAM, the neural 
cell-adhesion molecule (NCAM) results in disrupted HPA-axis responsiveness (Stork, 
Welzl, Cremer, & Schachner, 1997). It is reasonable, therefore, to hypothesize that 
disruption of guidance molecules that are enriched in limbic circuitry may result in 
altered neurodevelopment of those circuits, with outcomes that disrupt emotional 
regulation. 
 
The Limbic System Associated Membrane Protein 
 The limbic system associated membrane protein (protein: LAMP, gene: Lsamp) is 
of compelling interest to the study of the biological mechanisms of emotional regulation 
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because it is a developmentally relevant molecule that is expressed primarily in limbic 
circuitry. LAMP is another CAM of the IgSF family. It is a 64- to 68-kDa protein with 
three immunoglobulin domains, a glycosyl-phosphatidylinositol (GPI) anchor to the cell 
membrane (Pimenta, Fischer, & Levitt, 1996; Pimenta et al., 1995) and three possible 
isoforms (Pimenta & Levitt, 2004). The gene is highly conserved among species. There is 
99% homology in LAMP protein between human and rodent (Pimenta, Fischer et al., 
1996) and similar distribution patterns in birds (Yamamoto & Reiner, 2005; Yamamoto, 
Sun, Wang, & Reiner, 2005), rat (Levitt, 1984; Reinoso, Pimenta, & Levitt, 1996; Zacco 
et al., 1990), monkey (Cote, Levitt, & Parent, 1995, 1996) and human (Prensa, Gimenez-
Amaya, & Parent, 1999; Prensa, Richard, & Parent, 2003). In the adult, LAMP resides on 
the somata and dendrites of neurons (Levitt, 1984) and Lsamp expression is moderate to 
heavy in classic limbic areas and associated midbrain and hindbrain structures (Table 1) 
(Reinoso et al., 1996). More specifically, in the amygdala, Lsamp expression is moderate 
in the CeA and MeA, and high in BLA. PFC expression is high, as it is in other limbic 
cortical areas, such as cingulate cortex. Lsamp is expressed densely throughout all 
subfields of the hippocampus. Lsamp is expressed densely throughout parts of the 
hypothalamus including the PVN, although expression in the parvocelluar part is more 
moderate. The BNST and LC have moderate expression levels. There is sparse 
expression in the periaqueductal gray.    
 Lsamp expression begins early in embryonic development in post-mitotic 
neurons, around E13 in the rat, and has a distribution pattern similar to that of the adult 
(Pimenta, Reinoso, & Levitt, 1996). During early development, when limbic pathways 
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Table 1. Distribution of Lsamp expression in the adult brain. 
(Adapted from Reinoso et al., 1996). 
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 are forming, LAMP is present not only on neuron soma and dendrites, but also is present 
on axons (Horton & Levitt, 1988). The presence of LAMP on axonal growth cones 
provides the ability for LAMP to guide the formation of limbic pathways and there is 
much evidence to support this. In vitro analysis has shown that antibody perturbation of 
LAMP disrupts axonal targeting from septum to hippocampus, without affecting general 
axon outgrowth (Keller, Rimvall, Barbe, & Levitt, 1989). Addition of LAMP increases 
axonal branching in explants of cortical and thalamic limbic neurons, but has no effect on 
branching in non-cortical areas (Mann, Zhukareva, Pimenta, Levitt, & Bolz, 1998; V. V. 
Zhukareva, N. Chernevskaya, A. Pimenta, M. Nowycky, & P. Levitt, 1997). LAMP also 
promotes neurite outgrowth in limbic neurons while inhibiting outgrowth of non-limbic 
neurons (Eagleson et al., 2003; Pimenta et al., 1995; V. Zhukareva, N. Chernevskaya, A. 
Pimenta, M. Nowycky, & P. Levitt, 1997). In vivo, antibody perturbation of LAMP 
causes aberrant projection of mossy fibers in the developing hippocampus (Pimenta et al., 
1995). These results demonstrate that LAMP has an important role in the assembly of 
limbic circuitry and that disruptions in LAMP will cause alterations in that circuitry.  
 There are several examples of additional evidence linking LAMP to the 
modulation of emotional regulation. In a study of the exploratory behavior of rats on the 
elevated plus maze, rats that demonstrated reduced anxiety, as measured by entries and 
time in the open arms, also exhibited reduced Lsamp expression in the periaqueductal 
grey, amygdala and hippocampus (Nelovkov, Areda, Innos, Koks, & Vasar, 2006; 
Nelovkov, Philips, Koks, & Vasar, 2003). Lsamp expression is also down-regulated 
during the critical period in which maternal care is responsible for modulating 
development of the behavioral and physiological responses to stress. Champagne et. al. 
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recently demonstrated that Lsamp expression is decreased in the PVN of the offspring of 
high licking-grooming dams on postnatal days 1 and 7 (unpublished data); the period 
when maternal care regulates the development of limbic circuits responsible for 
mediating the stress response. These investigators hypothesized that differential 
expression of Lsamp during this critical period of development may cause altered 
patterning and wiring of limbic circuitry, which subsequently creates the structural basis 
for early “programming” of individual differences in HPA axis activity (Danielle 
Champagne, personal communication). There have also been several recent studies of 
polymorphisms in Lsamp associated with panic disorder, and male suicide, both disorders 
of emotional regulation (Koido et al., 2006; Maron et al., 2006; Must et al., 2008). Taken 
together, these studies provide strong evidence that LAMP is involved in the 
development of the circuits that underlie emotional regulation. 
 Our laboratory has developed mice in which the Lsamp gene is deleted, creating a 
unique model to examine the functional consequences of disrupting limbic circuit 
assembly. We propose to examine Lsamp
-/-
 mice for alterations in emotional regulation 
and in the limbic circuitry that is responsible for creating and modulating the behavioral 
and physiological responses to stress. Utilizing behavioral tests that measure exploratory 
behavior and activity in response to a novel environment will reveal what behavioral 
disruptions occur in response to stress when Lsamp is not expressed. Examining the 
timing and magnitude of the HPA axis stress response in Lsamp
-/-
 mice will demonstrate 
if LAMP is necessary for a normal neuroendocrine response to stress. In addition, studies 
to determine if Lsamp
-/-
 mice have altered stress-induced activation patterns in the 
circuits that are involved in stress-related behavior and that normally express LAMP, will 
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be the first step in determining the effect of disrupting LAMP on limbic circuit 
development and structure. We hypothesize that Lsamp
-/-
 mice will have developmental 
disruptions in limbic circuit formation that have long-term effects on limbic circuit 
structure and functional response to stress. 
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CHAPTER II 
 
GENETIC DELETION OF LSAMP CAUSES EXAGGERATED BEHAVIORAL 
ACTIVATION IN NOVEL ENVIRONMENTS 
 
 
Introduction 
 The limbic system is comprised of interconnected brain structures responsible for 
emotional regulation, cognitive function and autonomic responses. Although first 
described more than 120 years ago (Broca, 1878), hypotheses regarding the functional 
organization and specific contributions of the basic circuitry to complex behaviors are 
under continuous refinement. There is even debate regarding the limbic system as a 
unifying concept (Dalgleish, 2004; Heimer & Van Hoesen, 2006). Yet, specific frontal 
and temporal cortical areas, forebrain regions (septum, amygdala, hypothalamus) and 
brainstem nuclei (locus coeruleus, raphe, vagal nuclei) are implicated in the behavioral 
and physiological disruptions that cause neuropsychiatric diseases such as anxiety, 
depression and psychosis.  However, the underlying, complex changes at the circuit level 
remain ill-defined (Millan, 2003). A neurodevelopmental etiology has been hypothesized 
for many psychiatric disorders (Ansorge, Hen, & Gingrich, 2007; Gross & Hen, 2004; 
Lewis & Levitt, 2002; Weinberger, 1995), suggesting that the functional impact may 
occur through the disruption of the assembly of limbic circuitry. One approach to 
examine the development, maintenance and disruption of limbic-related behaviors is to 
manipulate the expression of molecules that mediate the development and function of the 
underlying neural circuitry. 
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The limbic system-associated membrane protein (LAMP), a cell adhesion 
molecule (CAM) of the IgLON family expressed in cortical and sub-cortical limbic-
associated regions of the developing and adult brain (Cote et al., 1995, 1996; Horton & 
Levitt, 1988; Levitt, 1984; Pimenta, Reinoso et al., 1996; Reinoso et al., 1996; Zacco et 
al., 1990) is one such molecule. The protein exhibits 99% homology between rodent and 
human (Pimenta, Fischer et al., 1996) and there is a close correlation between Lsamp 
mRNA and protein distribution patterns in rat (Levitt, 1984; Pimenta, Reinoso et al., 
1996; Reinoso et al., 1996; Zacco et al., 1990), monkey (Cote et al., 1995, 1996), and 
human (Prensa et al., 1999; Prensa et al., 2003). Experimental manipulations of LAMP in 
vitro result in altered axon targeting and neurite growth (Eagleson et al., 2003; Keller et 
al., 1989; Mann et al., 1998; Pimenta et al., 1995; V. V. Zhukareva et al., 1997). In the 
analysis of different rat substrains, Nelovkov and colleagues correlated lower expression 
of Lsamp mRNA in the amygdala and hippocampus with decreased anxiety and increased 
exploration (Nelovkov et al., 2006; Nelovkov et al., 2003). Moreover, there is genetic 
association of a polymorphism in the Lsamp gene with panic disorder in humans (Koido 
et al., 2006; Maron et al., 2006). Both studies suggested that alterations in LAMP may 
have functional consequences on complex behaviors. 
We have developed mice in which the Lsamp gene is deleted constitutively.  
Here, we have evaluated gross neuroanatomical organization and characterized the 
behavioral phenotype of Lsamp
-/- 
mice by providing an assessment of their response to 
novel, stressful environments as measured by activity and exploratory behavior. The 
results of this study support the importance of LAMP in limbic function and provide the 
basis for further anatomical, physiological and biochemical phenotyping of Lsamp
-/- 
mice. 
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Materials and Methods 
 
Lsamp targeting   
 To disrupt the Lsamp gene, we generated a targeting vector that replaced 69 nt of 
exon 2 including the 3’ splice site and 31 nt of intron 2 with a neo cassette inserted in the 
opposite transcription/translation frame relative to the Lsamp gene (Figure 1a). To 
generate the targeting vector, a mouse 129/ReJ genomic library constructed in the FIX 
II vector (provided by Dr John Pintar, UMDNJ-RWJMS, Piscataway, NJ) was screened 
using probes derived from the rat Lsamp cDNA (Pimenta et al., 1995). Among the Lsamp 
genomic clones isolated and characterized, the mLsamp--11a clone was selected for 
containing a 13.2 kb insert, including the partial nucleotide sequence of the first intron, 
exon 2 and ~4.0 kb of intron 2. The linearized vector was electroporated into R1 ES cells 
((129X1/SvJ x 129S1/Sv)F1-Kitl
+
). Targeted ES cells were injected into C57BL/6J 
blastocysts to generate chimeric mice. One heterozygous Lsamp founder was obtained 
and back-crossed into the C57BL/6J strain for more than 10 generations for all 
experiments reported here.  Initial genotyping was done by Southern Blot analysis. All 
subsequent mice were genotyped by polymerase chain reaction (PCR) amplification 
using primers to identify the presence of the wild type allele (5`- GTC CTG ATT GGT 
CTT GTT GAG TCC -3` and 5`- TCT TAT CCC ACT TCC CCC TTA CC -3`) and the 
targeted allele (5`-CTC CTG CCG AGA AAG TAT CCA TC-3` and 5`-CTC TGG AAT 
ACA GCC TCC GAA TC-3`). PCR reactions were performed using the AmpliTaq gold 
system (Applied Biosystems, Foster City, CA). 
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Figure 1. Targeted disruption of the Lsamp gene.  (a) Restriction map of the Lsamp
+/+
 
genomic nucleotide sequence surrounding Lsamp exon 2 indicates the region of 
homology selected for construction of the targeting vector. The schematic representation 
of the mutated allele represents the homologous recombination event that disrupted the 
Lsamp locus. The location of the 5’ probe used for the screening of the targeted event is 
indicated.  (b) Northern blot of Lsamp
+/+
 (lanes 1,2) and Lsamp
-/-
 (lanes 3,4) mRNAs 
from hippocampus (lanes 1,3) and cerebellum (lanes 2,4).  Three bands representing 
different sized Lsamp transcripts are evident in the Lsamp
+/+
 samples. Note the absence of 
message in the samples harvested from null mice. (c) Membrane extracts from 
cerebellum (lanes 1,3) and hippocampus (lanes 2,4) were analyzed by Western blotting.  
Samples from Lsamp
+/+
 mice (lanes 1,2) exhibit a single band of approximately 64-68kD, 
whereas samples harvested from Lsamp
-/-
 mice (lanes 3,4) do not have this band. As a 
control, lane 5 depicts LAMP recombinant protein that is the same molecular mass as the 
native protein.  Abbreviations for restriction enzymes: B, BamH I; E, EcoR I; H, Hind III; 
N, Nco I. Figure credit: Dr. Aurea Pimenta. 
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GeneBank accession number for the rat Lsamp nucleotide sequence is U31554.  
LSAMP/Lsamp are respectively the symbols for the human and rodent gene encoding 
LAMP, its mRNAs and cDNAs, approved by the human and mouse gene nomenclature 
committees.  LAMP is the designation for the protein (Zacco et al., 1990).”    
Unless otherwise indicated, all standard molecular biology techniques were 
performed as described by Ausubel et. al. (1998) and Sambrook et. al. (1989). All animal 
experiments were approved by the Vanderbilt University Institutional Animal Care and 
Use Committee and were conducted following the Guide for the Care and Use of 
Laboratory Animals (National Institutes of Health Publication No. 80–23, revised 1996). 
 
Northern Blot Analysis 
 Total cellular RNA was isolated from adult mouse hippocampus and cerebellum 
using the TRIzol reagent (Invitrogen, Carlshad, CA) following manufacturer’s protocol.  
The poly(A)
+
 RNA fraction was purified using the Oligotex mRNA isolation system 
(Qiagen). Poly(A)
+
 RNA (1 mg) was separated on a 1.5% agarose-formaldehyde gel, 
transferred to a nylon membrane (Nytran SuperCharge, Schleicher and Schuel, Keene, 
NH), UV cross-linked, and hybridized overnight under stringent conditions with 
32
P-
labeled cRNA probes. Antisense probes were transcribed in vitro using T7 RNA 
polymerase from rat Lsamp cDNA template (Pimenta et al., 1995) linearized with MscI 
(nt 464-1238). GeneBank accession number for the rat Lsamp nucleotide sequence is 
U31554. 
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Western Blot Analysis 
 Crude membrane preparations of hippocampus and cerebellum from adult mice 
were solubilized with 4% CHAPS (Zacco et al., 1990; Zhukareva & Levitt, 1995), 
separated on 10% PAGE using standard methods (Laemmli, 1970) and blotted onto 
nitrocellulose membranes. LAMP immunoreactivity was detected using a chicken anti-
LAMP polyclonal antibody, produced by Ames Laboratory (Tigand, OR) against 
recombinant protein that was purified to homogeneity in our laboratory. Specificity of the 
purified IgY fraction was characterized in our laboratory using Western Blot analysis. 
This polyclonal antibody specifically recognizes recombinant LAMP as well as a single, 
64-68kDa band corresponding to native LAMP from crude membrane brain extracts.  
 
Histological Analysis 
 Standard cresyl violet and Kluver-Barrera stains (Kluver & Barrera, 1953) were 
used for analysis of general gray matter cytoarchitecture and myelination. A monoclonal 
antibody (4A11) that recognizes neurofilament-H (NF-H) (Pimenta, Strick, & Levitt, 
2001) was used to map the general organization of forebrain fiber tracts. The antibody 
was used at a 1:100 dilution, followed by a standard HRP/DAB reaction (Pimenta et al., 
2001). Acetylcholinesterase histochemistry (Robertson, Mostamand, Kageyama, 
Gallardo, & Yu, 1991) was used for the assessment of the organization of the septo-
hippocampal cholinergic pathway. The fixation, sectioning of tissue and all standard 
histological procedures and stains, unless otherwise indicated, were performed as 
described by Hockfield et al. (1993). Complete serial sections from 3-5 animals of each 
genotype were examined at postnatal day (P) 6, P16 and adults. 
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Behavior 
 As noted above, all adult mice used for the behavior studies were backcrossed for 
more than 10 generations the C57BL/6J background. Mice were housed on ventilated 
racks in Plexiglas shoebox cages filled with CareFresh shredded paper bedding 
(Absorbtion Corp., Bellingham, WA). Mice were housed in groups of 2-5 per cage and 
given access to food (Lab Diet Rodent Chow 5001, PMI Nutrition International, 
Brentwood, MO) and water ad libitum. The colony was temperature (22.22±1°C) and 
light controlled (12 hour light/dark cycle, lights on at 6 a.m. CST).  All animals for these 
studies were obtained by heterozygous breedings. Lsamp
-/-
 mice and their wildtype 
(Lsamp
+/+
) littermates were used for all behavioral tests. Behavioral testing was 
performed in the Vanderbilt Kennedy Center and Center for Molecular Neuroscience 
Murine Neurobehavioral Core. Mice were tested between 3-6 months of age and were 
behaviorally naïve at the time of testing except for those in the 30 minute activity 
chamber experiment (see section 2.5.3.2). In all adult testing, males and females were 
tested in separate groups. All testing took place between 12-6 p.m. Housing and testing 
procedures were approved by the Vanderbilt University Institutional Animal Care and 
Use Committee. For all behavioral testing, sample sizes for each genotype and sex ranged 
from 7-16 animals/group. Specific group sizes are noted for each test in the figure 
legends. Strategies for analytical and statistical procedures were developed with 
consultants in the Vanderbilt Kennedy Center Statistics and Methodology Core. In all 
cases where coding was done by hand, coders (blind to genotype) achieved inter-rater 
reliability of greater than 95%. In all tests where there was a main effect of sex, the sexes 
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were then split, a new omnibus was performed and subsequent analysis was performed 
separately.  
 Postnatal development  
 The first litters born from Lsamp heterozygous breeding pairs were monitored 
daily in their homecage during the first postnatal week for nesting, feeding and postnatal 
lethality. Sensorimotor responses and body weight were used to assess the postnatal 
development of the Lsamp mice. Mice were tested and scored at P3-P5, P7, P14 and P21, 
as described by Fox (1965): righting reflex, postural flexion and extension, limb 
grasping, negative geotaxis, bar holding, cliff drop-aversion, tail suspension and visual 
placing.   
 Acoustic startle and prepulse inhibition 
 Apparatus. The acoustic startle reflex and prepulse inhibition (PPI) of the acoustic 
startle reflex were evaluated using four identical, ventilated, sound-attenuated acoustic 
chambers (515531 cm; Med Associates, St. Albans, VT, USA), each equipped with 
two speakers, a mouse holder and a transducer system through which startle responses 
were recorded. Chambers were connected to an amplifier and to a computer equipped 
with the Startle Reflex software (MED Associates).
  
 Testing Procedures. Group housed mice were handled for the three days 
preceding testing and were acclimated for one hour in an adjacent room on testing day.  
PPI was performed following the behavioral core protocol as previously described 
(Howard et al., 2002). Each mouse was placed in a holder that was then mounted on the 
response platform. Test sessions were preceded by a 5 minute acclimation period in the 
startle chambers during which a
 
65-dB background noise was continuously present, 
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followed by 54 trials in 9 blocks of 6 trials each. Each six-trial block contained one startle 
trial (40-ms, 120-dB burst of white noise), one null trial (no stimulus) and four prepulse 
trials (20-ms
 
bursts of 70-, 76-, 82-, and 88 dB white noise; followed 100 ms later by the 
startle stimulus). The trials in which no stimulus was presented were used to measure 
baseline movement in the cylinders. The six different trial types were pseudo-randomly
 
assigned. The inter-trial interval ranged from 10-20 s with an average of 15s. Mice were 
exposed to the EPM for 5 minutes ten days prior to this test.   
 Analysis and Statistics. PPI was calculated as the percent reduction in maximal 
startle on prepulse versus startle only trials. PPI data were analyzed using repeated 
measures ANOVA. 
 Activity Chamber 
 Apparatus. The activity chambers (MED Associates, Georgia, VT) were square 
arenas (27cm x 27cm x 20cm) with clear Plexiglas walls and white floors. An infrared 
beam break system positioned 1 cm above the floor on both the x and y axis was used to 
monitor mouse horizontal movements.   
 Testing Procedures. Group-housed mice were handled once daily for the three 
days preceding testing. Mice were transported into the testing room one at a time from an 
adjacent room, placed in the middle of the novel activity chamber and allowed to explore 
the chamber for 30 minutes. The chambers were illuminated at 550-650 lux and a white 
noise generator was placed in the room. Activity chambers were cleaned with water and 
70% ethanol between each animal. Male and female mice were run on the y-maze for 8 
minutes one week prior to this experiment. Exploration and alternation in the y-maze is 
dependent on novelty; therefore, y-maze was run prior to measuring activity. However, a 
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second cohort of behaviorally naïve, unhandled male mice was used to monitor activity 
over a one-hour time period. 
 Analysis and Statistics. The beam break data collected using the Med Associates 
software was used to measure the total distance (cm) traveled per ten-minute block. For 
the 30-minute trial a repeated measures ANOVA was used with genotype and sex as 
between subject factors and distance traveled as within subjects factor. For the 1-hour test 
(males only) data were analyzed using repeated measures ANOVA with genotype as the 
between subjects factor. If the omnibus test detected a significant effect for genotype, or 
genotype*behavior, a post-hoc t-test was performed to determine at which time points the 
differences occurred. 
 Elevated Plus Maze 
 Apparatus. The elevated plus maze (EPM) was a plus shaped apparatus consisting 
of two open arms (platforms with no sides) and two closed arms (platforms with tall 
walls) connected by a small center square. Both the open and closed arms of the maze 
were 30 cm long x 5 cm wide with white Plexiglas floors. The closed arms had 15 cm 
high walls made of black Plexiglas and the open arms were equipped with a 0.25cm high 
Plexiglas edge on the sides and ends to decrease the chance of mice falling off the maze.  
The center box was 5 x 5 cm. The maze was built on 40 cm high legs and placed on the 
floor for testing. Four white screens were placed around the maze in order to reduce 
spatial cues from the room. 
 Testing Procedures. In all EPM experiments, animals were brought into the 
testing room one at a time from a neighboring room, placed in the center of the maze and 
allowed to freely explore for 5 minutes. Mice were naïve and not handled prior to 
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exposure to the EPM. A white noise generator was present in the room for all 
experiments and a camera was placed directly above the maze to record the behavior of 
each animal.  The maze was illuminated at approximately 250 lux. The maze was cleaned 
with water and 70% ethanol between each animal. Additional cohorts of animals were 
run under dimmer lighting conditions (~ 60lux) and after being handled, but there was no 
statistical effect of these environmental manipulations on any of the standard EPM 
measures. 
 Analysis and Statistics. The number of entries into the open and closed arms, and 
duration of time spent in open arms, closed arms and center of the maze were measured 
for each animal. Entries and exits from maze arms were defined as all four paws crossing 
into or out of the arm. Additionally, as an indication of risk assessment, we measured 
both unprotected and protected head-dipping. Unprotected head-dips were defined as the 
head, neck and shoulders of the mouse crossing off the edge of an open arm while all four 
paws were in an open arm. Protected head-dips were defined as the head, neck and 
shoulders of the mouse crossing off the edge of an open arm while at least one paw was 
in either the center or closed arms of the maze. Entries and durations measurements were 
automated using the MazeScan suite of TopScan video analysis software (CleverSys Inc., 
Reston VA). TopScan measurements were validated by comparison to hand scoring by a 
trained, observer blind to genotype. The hand coding was performed from video using 
ProcoderDV (Vanderbilt University, Nashville TN) and correlations between TopScan 
and hand coding were greater than 0.90 for all measurements. A trained observer blind to 
genotype manually coded head-dips. Each of the three specific behavior categories 
(entries, duration and head-dips) was analyzed separately. An omnibus repeated measure 
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ANOVA was performed for each with genotype and sex as between subject factors and 
area of the maze (i.e. open/closed arm, protected/unprotected area) as the within subject 
factors. To control for analyzing data from multiple EPM measures, a Bonferroni-
corrected alpha (0.0167) was used. Significant genotype or genotype*behavior effects 
were followed by post-hoc t-tests. 
 Y-maze 
 Apparatus. The y-maze was a y-shaped apparatus in which the three arms were of 
equal length.  The three enclosed arms were made of clear circular Plexiglas and the 
bottom of the Plexiglas tube was removed so that the maze sat flat on a grey rubber 
surface. Each arm was 30.5cm long x 4.8 cm wide x 4.3 cm tall.  The end of one arm was 
removable for placement of mice in the maze. The arms of the maze joined in the center 
with each arm at a 120° angle from the next. Spatial cues were available to the mice 
during testing (e.g. walls, door to room, shelving in room).  
 Testing Procedures. Male and female mice were naive prior to the y-maze test.  
All mice were handled for three days prior to testing. Mice were transported into the 
room one at a time from a neighboring room and placed in the end of one arm of the y-
maze. They were allowed to freely explore the chamber for 8 minutes. A camera was 
placed directly above the maze to record the animal’s behavior.  The room was 
illuminated at approximately 200 lux. The maze was cleaned with water and 70% ethanol 
between each animal. 
 Analysis and Statistics. A trained observer blind to genotype scored the number 
and sequence of arm entries in the y-maze. An arm entry was defined as all four paws 
crossing into an arm. The number of spontaneous alternations, same arm returns and  
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Table 1: Lsamp
 -/-
 mice are fertile and show normal growth. 
 
Measures Lsamp
 -/-
 Lsamp 
+/+
 
Body weight, P6  
 
3.5 +/- 0.6 (n=13) 
 
3.6 +/- 0.4 (n=10) 
 
Body weight, P7 
 
4.0 +/- 0.5 (n=36) 
 
4.1 +/- 0.7 (n=53) 
 
Body weight,  P14 
 
7.4 +/- 1.0 (n=19) 
 
7.2 +/- 0.6 (n=20) 
 
Body weight, P21 
 
10.0 +/- 1.4 (n=6) 
 
10.4 +/- 1.2 (n=12) 
 
Body weight, Adult males  
 
29.3 +/- 2.0 (n=19) 
 
28.4 +/- 2.0 (n=17) 
 
Body weight, Adult females  
 
22.1 +/- 1.7 (n=50) 
 
22.5 +/- 1.9 (n=52) 
 
Brain weight, Adult male  
 
0.48 +/- 0.01 (n=20) 
 
0.48 +/- 0.02 (n=20) 
 
Fertility 
 
Male and Female mice are fertile 
  
Nesting and feeding   
(P0-P7) 
 
All mice in nest; milk plaque present 
 
 
Lethality 
 
No neonatal lethality associated with genotype 
  
Body and brain weight values in grams 
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 alternate arm returns were then determined. Spontaneous alternations were defined as 
entries into each of the three arms in a sequential manner. Same arm returns (SAR) were 
defined as re-entering the same arm that was just visited after all four paws left the arm 
and before any other arm was entered. Alternate arm returns (AAR) were defined as entry 
into two of three arms in three sequential entries where the same arm was entered at the 
beginning and end of the triplet (e.g. arm A,B,A). Percent spontaneous alternation for 
each animal was calculated as the ratio between the number of actual spontaneous 
alternations (#SA) and the total number of possible spontaneous alternations (total entries 
– 2) multiplied by 100: (#SA/(total entries-2))*100. Alternate arm returns and same arm 
returns were calculated as a ratio of returns to total number of entries multiplied by 100 
(e.g. (AAR/total entries)*100). A MANOVA was calculated using four measures (total 
entries, %SA, %AAR and %SAR) including sex and genotype as factors.  
 
Results 
 
Initial characterization of Lsamp
-/-
 mice 
 The targeting event resulted in disruption of the Lsamp locus (Figure 1a).  As a 
consequence of this genetic manipulation, the mutant mice lack both Lsamp transcripts 
and LAMP protein as determined by Northern and Western Blot analysis, respectively 
(Figure 1b and c). Analysis of over 250 litters, congenic into C57BL/6J strain, revealed 
an expected Mendelian ratio of +/+, +/- and -/- genotypes, reflecting normal viability in 
utero and postnatally. Lsamp
 -/- 
mice were normal in appearance, size, growth and 
development. There were no differences in monitored weight gain and brain weight was  
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Figure 2. Histological analysis of adult Lsamp
-/- 
mice. Coronal section images taken at the 
level of rostral hippocampus of Lsamp
+/+
 and Lsamp
-/-
 littermates. Note the normal 
cytoarchitecture of the cerebral cortex (ctx), hippocampus (H), amygdala (A), thalamic 
ventral basal complex (VB) and hypothalamus viewed by cresyl violet staining (a).  
Major fiber tracts, viewed by immunostaining with a neurofilament-H antibody (b), also 
appear normal in Lsamp
-/-
 mice compared to their Lsamp
+/+ 
counterparts. Limbic 
structures and fiber tracts show normal distribution of AChE histochemistry in both 
genotypes (c). N=5/genotype for each histological staining. Scale bar =1mm. Figure 
credit: Dr. Aurea Pimenta. 
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identical for Lsamp
 -/-
 and Lsamp
 +/+
 male littermates (Table 1). The gross anatomy of the 
brain was normal. Thus, white matter staining, general gray matter cytoarchitecture and 
the appearance of forebrain cortical and subcortical structures did not differ across 
genotypes. For this initial screening, several immuno- and histochemistry stains were 
used.  Normal cytoarchitecture and fiber tracts are illustrated in Figure 2. Cortical 
lamination patterns and amygdala and thalamic nuclei all appear intact and well-
delineated. In addition, commissural pathways throughout the forebrain were intact.  
AChE histochemistry indicated a normal patterning of the septo-hippocampal cholinergic 
pathway, differing from experimental studies in vitro (Keller et al., 1989; Zhukareva & 
Levitt, 1995). Normal AChE reactivity (Figure 2c) is depicted in the hippocampus, 
amygdala, caudal striatum, limbic thalamic nuclei and lateral hypothalamus. Strong 
reactivity identifies cholinergic fibers in the internal capsula and the mammillothalamic 
tract in both genotypes. Thus, there currently is no indication from basic neuroanatomical 
examination of major alterations in brain organization and gross connectivity in the 
Lsamp
-/-
 mouse. 
 
Behavioral Analysis 
 Lsamp
-/-
 mice were indistinguishable from littermates from the day of birth. The 
overall motor and sensory development of Lsamp
-/-
 mice was evaluated from P3-P21 
using a selected battery of tests (Fox, 1965). In all sensorimotor tests used, Lsamp
-/-
 mice 
acquired and performed mature responses at the same rate and ability as did their 
wildtype littermates (Table 2), demonstrating normal reflex maturation and normal gross 
sensory and motor abilities. 
 44 
 
 
 
 
Table 2: Sensory and motor development of Lsamp
-/-
 mice. 
 
  
Measures of development  
                            
Mature Responses in Lsamp 
-/-
 mice 
 
 P5 P7 P14 P21 Adult 
Righting  85 100       
Postural flexion/extension normal normal       
Forelimb grasping   100 100    
Hindlimb grasping     100    
Inverted screen holding     100 100   
Negative geotropism 
  
 100 100     
Bar holding     100 100   
Cliff drop aversion     100 100   
Tail suspension     100 100   
Visual Placing        100   
Eyelid opening     open     
Startle          normal 
Pre-pulse inhibition         normal 
Acquisition of mature responses in Lsamp 
-/-
 are expressed as percentage of animals 
expressing a mature response (Score = 9). 
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Acoustic startle response and prepulse inhibition of acoustic startle 
 The acoustic startle response and sensory motor gating were evaluated in adult 
mice. There was no difference in the amplitude of the startle responses between Lsamp
 -/-
 
and Lsamp
 +/+
 mice, and no deficits in PPI (Figure 3). In addition, no differences in 
baseline levels of movement were found between genotypes in the “no stimulus” trials 
(Figure 3a).  There was a significant decrease in startle with increasing prepulse stimuli 
in both genotypes (F(3,78) =  33.38, p < 0.0001), demonstrating the effectiveness of the PPI 
protocol (Figure 3b). These data are consistent with intact circuitry involved in the 
acoustic startle reflex and in those circuits that modulate PPI in the Lsamp
 -/- 
mice. 
 
Activity Chamber 
 Lsamp
-/-
 mice displayed hyperactivity during exposure to a novel open arena.  
Activity data during the 30-minute test for females and males are displayed in Figure 4. 
The initial repeated measures ANOVA demonstrated main effects of sex (F(1,54) = 5.47, p 
= 0.023), genotype (F(1,54) = 18.58, p < 0.0001), and distance traveled over time (F(2,54) = 
129.21, p < 0.0001). There also was a significant interaction of time X genotype (F(2,108) = 
11.172, p < 0.0001). Because there was an effect of sex, male and female data were split 
for the subsequent analyses. There was a main effect of genotype on distance traveled 
over time for both females (F(1,28) = 4.84, p = 0.0002) and males (F(1,26) = 14.73, p = 
0.0007), and an interaction of genotype X distance traveled (F(2,56) = 10.33, p = 0.0001 
and F(2,52) = 4.10, p = 0.022, respectively). Both female and male Lsamp
-/-
 mice traveled a 
significantly greater distance than did their Lsamp
 +/+
 littermates during the first ten 
minutes of the test (t(28) = 3.71, p = 0.0009 and t(26) = 3.86, p = 0.0007). During the 
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Figure 3. Normal acoustic startle response and sensorimotor gating in Lsamp
-/-
 mice. 
Startle amplitude (a) and prepulse inhibiton of acoustic startle responses over varying 
prepulse intensities (b) are shown for Lsamp
-/-
 mice (closed bars) and wildtype littermates 
(open bars) represented as mean±SE (n=14/group). Figure credit: Dr. Aurea Pimenta. 
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second and third ten-minute blocks of the test, female Lsamp
 -/-
 mice habituated to normal 
activity levels and did not significantly differ from Lsamp
 +/+
 during either time block 
(Figure 4a). However, male Lsamp
 -/-
 mice continued to display hyperactivity throughout 
the remainder of the 30-minute test (Figure 4b). 
 The highest levels of hyperactivity occurred during the first 10 minutes in both 
female and male Lsamp
 -/-
 mice. Female Lsamp
 -/-
 habituated to their environment during 
the 30-minute testing period. We thus hypothesized that the male Lsamp
 -/-
 mice may also 
habituate to normal activity levels if provided with an extended testing period. Therefore, 
we repeated the experiment with a new group of males but extended the length of time in 
the chamber to one hour (Figure 4c). Again, there were main effects of genotype (F(1,13) = 
7.04, p = 0.0199), distance traveled over time (F(5,13) = 42.39, p < 0.0001) and an 
interaction between the two (F(5,65) = 4.37, p = 0.0017). In the new group of mice, the 
period of greatest hyperactivity also occurred during the first 10 minutes of exposure to 
the novel chamber (t(13) = 3.56, p = 0.0035) and the male Lsamp
 -/-
 mice still displayed 
hyperactivity 30 minutes into the test (Figure 4c). During the ten minute bins of the final 
30 minutes of the test, however, Lsamp
 -/- 
mice did not travel a greater distance than did 
their Lsamp
 +/+
 littermates, indicating that like the females, the male Lsamp
 -/-
 mice 
eventually habituated to the novel environment. 
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Figure 4. Open field activity of Lsamp
-/-
 mice. The distance traveled, measured in 
centimeters (cm), by Lsamp
-/-
 mice and their Lsamp
+/+
 littermates is displayed in 10 
minute bins (a&b). Both female (a) and male (b) Lsamp
-/-
 mice exhibit hyperactivity 
when exposed to the novel arena. Female Lsamp
-/-
 mice habituate to normal levels of 
activity within 20 minutes of being placed in the arena, but male Lsamp
-/-
 mice remain 
hyperactive for the duration of the 30 minute test. (n=13-15/group). Examination of 
activity in the open field for a 60 minute period (c) revealed that the null mice return to 
normal levels of activity by the second half of the test period.  The increase in distance 
traveled by male Lsamp
-/-
 mice during the second 10 min bin (20) was not significant at p 
= 0.06 (n=7 WT, n=8 Lsamp
-/-
).*p<0.05 
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Elevated Plus Maze 
 There was no main effect of sex on either of the traditional measures used for 
EPM (entries and durations); therefore the sexes were combined for the remainder of the 
analyses. The results of the EPM are presented in Figures 5 (entries, duration) and 6 
(head-dips). There was a main effect of genotype (F(1,28) = 39.44, p < 0.0001) on the 
number of entries and an interaction between category of entry and genotype (F(1,28) = 
22.37, p < 0.0001). Lsamp
-/- 
mice demonstrated an increased number of entries into both 
the open (t(30) = 6.59, p < 0.0001) and closed (t(30) = 2.27, p < 0.031) arms of the maze 
(Figure 5a). The Lsamp
 +/+
 mice made more than double the number of closed entries as 
open entries (means±SE of 11±0.8 vs. 5±0.6), whereas Lsamp
 -/-
 mice made a similar 
number of entries into the closed and open arms (14±0.72 and 16±1.5). There was no 
main effect of genotype on durations; however, there was an interaction between 
genotype and category of duration (F(2,56) = 67.20, p < 0.0001). This interaction occurred 
because Lsamp
 -/- 
mice spent more time in the open arms (t(30) = 3.88, p = 0.0005), with 
a corresponding decrease in center time (t(30) = 2.78, p = 0.0093), but no significant 
difference in time spent in the closed arms of the maze (Figure 5b). 
 Risk-assessment behavior on the EPM also was monitored by examining head-
dips. There were main effects of sex (F(1,28) = 11.31, p = 0.0022), genotype (F(1,28) = 
25.28, p < 0.0001) and area of the maze (F(1,28) = 75.38, p < 0.0001) on the number of 
head-dips. The omnibus test also detected interactions between genotype and area of the 
maze (F(1,28) = 35.82, p < 0.0001), and sex and area of the maze (F(1,28) = 6.73, p < 
0.0149). Since there was a main effect for sex, we split males and females for subsequent 
analyses on the contribution of genotype to altered head-dipping behavior. Omnibus 
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testing of each sex separately still detected an effect of genotype and an interaction 
between genotype and area of the maze in which head-dips occurred. Both female and 
male Lsamp
 -/-
 mice demonstrated a large increase in the number of unprotected head-dips 
(t(15) = 3.02, p = 0.0086 and t(13) = 5.70, p < 0.0001), while maintaining a normal 
number of protected head-dips as compared to Lsamp
 +/+
 littermates (Figure 6). Because 
the EPM was the only test in which animals were not handled before being exposed to the 
apparatus, we repeated the test with both handled male and female mice under slightly 
different environmental conditions (new room and reduced light levels). We combined 
data and analyzed across groups (taking into account sex, handling, and testing 
environment) and genotype. There was no effect of testing procedures on either entries or 
duration and the effect of genotype remains highly significant for both measures (F(1,28) = 
6.73, p < 0.0001 and F(1,28) = 6.73, p < 0.0001). Thus, regardless of environmental 
manipulations, Lsamp
-/-
 mice displayed hyperactivity, increases in open arm time, 
increases in open arm entries and increases in unprotected head-dips. 
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Figure 5. Lsamp
-/-
 mice behavior on the EPM. Lsamp
-/-
 mice make a significantly greater 
number of entries into both the open and closed arms of the EPM (a), indicating 
hyperactivity. Lsamp
-/-
 mice also reside for a longer duration (sec) in the open arms of the 
maze, with a corresponding decrease in the amount of time spent in the center (b). 
Because there was no effect of sex on traditional EPM measures, male and female mice 
were combined in these analyses. (n=16/group)*p<0.01 
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Figure 6. Exploratory behavior of Lsamp
-/-
 mice on the EPM. Measures of head-dips were 
quantified as a measure of risk assessment. Both female (a) and male (b) Lsamp
-/-
 mice 
make more than double the number of unprotected head-dips, compared to their Lsamp
+/+
  
littermates. There is no difference in the number of protected head-dips in null mice of 
either sex. (n=7-9/group)*p<0.01 
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 Y-maze 
 Y-maze data are presented in Figure 7. There was no main effect of sex on the y-
maze measurements, so data were combined across sex for the analyses. There was a 
main effect of genotype on y-maze measurements (F(4,49) = 17.70, p < 0.0001). As 
expected, Lsamp
 -/-
 mice were hyperactive during the 8-minute exposure to the novel y-
maze, as measured by a significant increase (F(1,52) = 53.43, p < 0.0001) in the total 
number of arm entries (Figure 7a). Lsamp
 -/-
 mice also demonstrated a small, but 
significant decrease (F(1,52) = 7.27, p = 0.011) in the percent spontaneous alternation 
(Figure 7b). The deficit in spontaneous alternation was accounted for by an increase 
(F(1,52) = 17.44, p = 0.0001) in alternate arm returns (Figure 7c). There is no change in the 
proportion of same arm returns (data not shown). 
 
Discussion 
 We found no evidence of gross changes in brain organization or connectivity in 
Lsamp
 -/- 
mice. This differs from previously reported findings using in vitro experimental 
paradigms in which LAMP mediated axon targeting and growth (Keller et al., 1989; 
Zhukareva & Levitt, 1995). The current analyses are more consistent with a role for 
LAMP mediating finely specialized aspects of circuit formation and maturation in 
regions of the limbic system. LAMP, a cell-surface molecule, is not a receptor for any 
known neurotransmitter or neuromodulator, consistent with the hypothesis that altered 
expression of the protein is likely to lead to differences in connectivity rather than direct 
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Figure 7. Spontaneous alternation by Lsamp
-/- 
mice in the Y-Maze. The Lsamp
-/-
 mice 
exhibit hyperactivity in the y-maze (a). There was a modest, but statistically significant 
decrease in spontaneous alternation in null mice (b), and an increase in alternate arm 
returns (c).  (n=27-29/group)*p<0.05 
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 changes in traditional neurotransmitter signaling. There are wide-ranging developmental 
effects of deletion of axon guidance and cell adhesion molecules, resulting in very subtle 
to gross changes (Barallobre et al., 2000; Sahay, Molliver, Ginty, & Kolodkin, 2003; 
Wiencken-Barger, Mavity-Hudson, Bartsch, Schachner, & Casagrande, 2004). Cell 
adhesion molecules such as L1, NCAM, neurexins/neuroligins, and ephBs/ephrins are 
involved in the regulation of synapse formation and stability (Dalva, McClelland, & 
Kayser, 2007). Deletion of these genes in model systems tends to result in more subtle 
defects that are consistent with most neuropathology found in psychiatric disorders, in 
which only modest changes at the cellular level (e.g. spine density, neuropil size, synaptic 
density) have been discerned (Lewis & Levitt, 2002). Thus, it is possible that for brain 
regions in which LAMP is expressed, neuronal signaling is only subtly disturbed, but 
may lead to measurable changes in functional output of the circuits that are disrupted. 
Accordingly, the initial analysis of the Lsamp
-/-
 mice demonstrates alterations of certain 
behaviors that relate to emotional reactivity in novel situations, without disruption of the 
development or maintenance of basic sensory and motor behaviors. This is reflected both 
by the normal developmental timing of sensorimotor responses and normal adult auditory 
startle and sensorimotor gating as measured by pre-pulse inhibition. 
 
Select Changes in Behavior in Lsamp
 -/-
 Mice 
 The behavior of mice in a novel environment reflects a balance between the desire 
to explore (motor and behavioral activation) and fear (motor and behavioral inhibition) 
(Crawley, 1985). In three of the behavioral tasks that we used, both male and female 
Lsamp
 -/-
 mice demonstrated heightened behavioral activation as measured by their 
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activity in a novel apparatus (distance in the activity chamber, entries on the EPM and 
entries in the y-maze). Lsamp
-/-
 mice displayed hyperactivity when first placed in an open 
field activity chamber, but habituated to the same baseline activity levels as their 
Lsamp
+/+
 littermates over time. This is consistent with our hypothesis that the Lsamp
 -/-
 
mice are not generally hyperactive, but rather are hyper-responsive to different novel 
environments. Increased locomotor activity as a response to a novel, stressful 
environment could be interpreted as increased behavioral activation, exploratory drive or 
as an inability to properly inhibit behavior in a threatening situation (Crawley et al., 
1997). Although these domains are likely to be linked both behaviorally and 
neurobiologically, our data suggest that in the absence of Lsamp, mice are at least 
exhibiting heightened behavioral activation. During the first 10 minutes of the test, mice 
of both genotypes demonstrate increased activity above baseline, reflecting genotype-
independent increased exploratory behavior during this time period. Male and female 
Lsamp
 -/-
 mice, however, have a heightened level of activity compared to their Lsamp
+/+
 
littermates even during this portion of the test, indicating an increase in behavioral 
activation.  
Increased activity also was evident in the EPM test. Lsamp
 -/-
 mice made a greater 
number of total arm entries, with a small increase in closed entries, exhibiting 
hyperactivity in the 5-minute exposure to a novel environment. Mice generally show a 
strong preference for the closed arms as measured by entries (Hogg, 1996), which was 
evident in the analyses of the Lsamp
+/+
 mice. However, Lsamp
 -/-
 mice showed no 
preference in entries for either open or closed arms. One reasonable interpretation of the 
greater proportion of open entries, even in the context of the overall increase in entries, is 
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a reduction in anxious behavior (Pellow & File, 1986). Alternatively, if the Lsamp
 -/-
 mice 
have an increased arousal state in response to stress, a lack of preference for either arm 
may reflect reduced behavioral inhibition and/or increased activation.  Lsamp
-/-
 mice also 
spend significantly more time in the open arms, which also is generally viewed as 
reflecting reduced anxiety. This conclusion follows from an ethological interpretation of 
the test and from the results of pharmacological manipulations, in which mice receiving 
anxiolytic drugs increase open arm time with a corresponding decrease in closed arm 
time, whereas anxiogenic drugs induce the opposite behaviors (Pellow & File, 1986).  We 
propose an alternative hypothesis, one in which interpreting the EPM data as reflecting an 
altered anxiety state in the Lsamp
 -/-
 mice may not be accurate. For example, the increase 
in open arm time is accounted for by a significant decrease in time spent in the center of 
the maze. When Lsamp
+/+
 mice do spend time in the center, they generally inhibit motor 
behavior, remaining still, and appear to be “sizing up” the open arms prior to deciding 
which area to enter. In contrast, the Lsamp
 -/-
 mice do not inhibit their movement and, 
therefore, enter the open arms of the maze much more frequently than the Lsamp
+/+
 mice. 
There is precedence for this view, as the Ts65Dn mutant mouse also demonstrates greatly 
increased motor output with corresponding anxiolytic-like EPM results. Because of the 
hyperactivity, however, these changes have been interpreted not as anxiety, but as a lack 
of behavioral inhibition or reduced attention to environmental stimuli (Coussons-Read & 
Crnic, 1996; Martinez-Cue, Rueda, Garcia, & Florez, 2006). While recognizing that a 
simple explanation would involve primary disruption of the anxiety state, we suggest that 
Lsamp
 -/-
 mice exhibit heightened reactivity to stressful stimuli, revealed by hyper-
activation and lack of appropriate behavioral inhibition. 
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Consistent with this view, heightened reactivity in the Lsamp
 -/-
 mice is evident in 
other behaviors, such as unprotected head-dips. Although there is a sex difference in 
degree of increase of unprotected head-dips, both male and female Lsamp
 -/-
 mice 
demonstrate increased risk assessment. Based on reports in the literature, the co-
segregation of increased unprotected head-dips and open arm exploration in the Lsamp
 -/-
 
mice is unusual. For example, factor analyses of mouse and rat behavior in the EPM 
revealed that increased head-dips load on the same factor as the traditional measures of 
anxiety, but is inversely correlated with open time and entries (Cruz et al., 1994; Rodgers 
& Johnson, 1995). In one study (Rodgers & Johnson, 1995), when protected and 
unprotected head-dips were analyzed separately, protected head-dips loaded on the 
anxiety factor, while unprotected head-dips did not fall into the categories discovered. 
Lsamp
 -/-
 mice do not show reduced head-dips in the protected portion of the maze, which 
would be associated with decreased anxiety. Instead, the increase in head-dips on the 
open arms of the EPM may be due to a combination of the increased time spent in the 
open arms of the maze and increased behavioral activation in open, more anxiety 
provoking areas of the maze. This interpretation again is consistent with the hypothesis 
that Lsamp
 -/-
 mice may experience behavioral hyper-activation or disinhibition in 
stressful environments. To gain further understanding and clarification of the underlying 
neurodevelopmental and molecular basis for these behavioral changes our laboratory is 
examining the integrity of the neural regulatory systems in which LAMP is expressed. 
  Spontaneous alternation in the y-maze takes advantage of the exploratory drive of 
rodents (Lalonde, 2002), in which animals typically investigate the newest area in an 
environment. The interpretation of deficits in alternation behavior can be complex 
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because quantitative differences in the pattern of exploration have been interpreted in 
other studies as a reflection of decreased attention, deficits in short-term memory, 
changes in arousal or anxiety (Hughes, 2004; Lalonde, 2002). Along with their 
characteristic hyperactivity, Lsamp
 -/- 
mice exhibit a significant, though very modest 
decreased level of spontaneous alternation during the period when novelty-induced 
hyperactivity peaks. It is unlikely that this indicates altered anxiety in the traditional 
sense, because such measures of anxiety are decreased in the Lsamp
 -/-
 mice. Instead, we 
suggest that the altered performance on the maze may be due to a disrupted state of 
arousal or deficits in working memory. Consistent with the interpretation of altered 
arousal is the finding that Lsamp
 -/-
 mice displayed heightened reactivity in other novel 
environments. However, in order to definitively address the underlying cause of 
spontaneous alternation deficits, including the possibility of deficits in working memory, 
further detailed testing will be required.  
Taken together, our data suggest that there is a complex behavioral deficit caused 
by the targeted deletion of the Lsamp gene. Rather than a primary defect in the regulation 
of anxiety state, we hypothesize that the mutation results in heightened and possibly 
maladaptive response to novel environmental stressors. This interpretation of the animal 
model experiments is consistent with the recent human genetic studies in which a 
polymorphism in the human Lsamp gene is associated with panic disorder in certain 
environments (Koido et al., 2006; Maron et al., 2006). Lsamp is expressed robustly 
throughout the limbic circuitry responsible for mediating an animal’s behavioral response 
to novelty (including circuitry that mediates fear, stress and exploratory behavior). 
Alterations in emotional regulation can be due both to direct changes in neurotransmitter 
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function (Hariri & Holmes, 2006; Howell & Muglia, 2006; Southwick, Vythilingam, & 
Charney, 2005; Wood & Toth, 2001) and to alterations of synaptic connectivity (Sandi & 
Bisaz, 2007; Wood & Toth, 2001). Because Lsamp is expressed from the time that 
neurons become postmitotic prenatally and throughout the life of the animal, conditional 
and reversible manipulation of gene expression will be necessary to determine whether 
the behavioral dysfunction exhibited by the Lsamp
 -/-
 mice are due to differential 
development of limbic circuitry, direct modulation of mature synaptic function in the 
adult, or even both. 
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CHAPTER III 
 
GENETIC DELETION OF LAMP CAUSES HEIGHTENED RESPONSIVENESS 
OF THE HPA AXIS IN NOVEL ENVIROMENTS 
 
 
Introduction 
 An animal’s ability to respond to stress appropriately, both physiologically and 
behaviorally, is critical to its success and survival. A major component of the stress 
response, the hypothalamic-pituitary-adrenal (HPA) axis is responsible for the 
neuroendocrine response to stress, in which corticosterone (CORT) is ultimately released 
into the bloodstream to modulate metabolism, blood flow and brain function (Armario, 
2006; Miller & O'Callaghan, 2002; Sapolsky, Romero, & Munck, 2000). Several limbic 
brain structures and related circuits modulate the likelihood of the para-ventricular 
nucleus (PVN) of the hypothalamus to release corticotropin releasing factor (CRF), the 
first step in the cascade (Herman et al., 2005). 
 It is well established that CORT can effect the expression and function of cell 
adhesion molecules (CAMs), such as L1 and NCAM (Grootendorst, Oitzl et al., 2001; 
Sandi & Loscertales, 1999; Venero et al., 2002). Furthermore, alterations in HPA-axis 
reactivity of the NCAM knockout mouse has provided evidence that CAMs can play an 
important role in stress regulation (Stork et al., 1997). The limbic system associated 
membrane protein (protein: LAMP, gene: Lsamp) is another CAM that is expressed 
embryonically and throughout adulthood in cortical and subcortical limbic structures and 
circuitry (Cote et al., 1995, 1996; Horton & Levitt, 1988; Levitt, 1984; Pimenta, Reinoso 
et al., 1996; Reinoso et al., 1996; Zacco et al., 1990). It is well established the alterations 
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during the period when limbic circuits are developing can cause long-term alterations in 
anxiety-like behaviors and HPA axis reactivity (Card, Levitt, Gluhovsky, & Rinaman, 
2005; Meaney, Aitken, Bodnoff, Iny, & Sapolsky, 1985; Meaney et al., 1993). Both its 
distribution and its role in axon guidance and neurite outgrowth in the developing brain 
(Eagleson et al., 2003; Keller et al., 1989; Mann et al., 1998; Pimenta et al., 1995; V. V. 
Zhukareva et al., 1997) provide LAMP the potential to alter the circuitry that underlies 
the stress response.  
 We have previously reported that Lsamp
-/-
 mice display exaggerated behavioral 
activation in novel environments, including hyperactivity and increased exploratory 
behaviors (Catania, Pimenta, & Levitt, 2008). We hypothesized that these behaviors are 
caused by a heightened, and possibly maladaptive, response to environmental stressors. 
Here, we investigate the stress responsiveness of Lsamp
-/-
 mice by examining their HPA 
axis response and brain activity when they are exposed to novel environment. 
 
Methods 
 
Animals 
 Fully backcrossed male, adult (3-6 months) Lsamp
-/-
 C57BL/6J mice and their 
wildtype littermates were used for all experiments (except one EPM experiment in which 
females were used. Lsamp
-/-
 mice were generated by homologous recombination as 
described in chapter 2, page 30 (Catania et al., 2008). All animals were obtained by 
heterozygous breedings. Mice were genotyped by polymerase chain reaction (PCR) 
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amplification as described in Chapter 2 (p. 30).   By conformity, the protein is 
abbreviated LAMP and the gene name, as archived in Genbank, is noted as Lsamp. 
Mice were group housed on ventilated racks in Plexiglas shoebox cages filled with 
CareFresh shredded paper bedding (Absorption Corp., Bellingham, WA) and given 
access to food (Lab Diet Rodent Chow 5001, PMI Nutrition International, Brentwood, 
MO) and water ad libitum. The colony was temperature (22±1°C) and light controlled (12 
hour light/dark cycle, lights on at 6 a.m. CST). The Vanderbilt University Institutional 
Animal Care and Use Committee approved housing and testing procedures. 
 
Corticosterone Assay 
 All testing and blood collection was done between 8 and 10 am (2-4 hours after 
lights on). Mice either remained undisturbed in their home cage (basal) or were placed 
individually in a standard homecage that had no bedding or wire lid (novel environment) 
until time of sacrifice. Mice were sacrificed by cervical dislocation followed by rapid 
decapitation either from the home cage or at 5, 15, 30, or 60 minutes after placement in 
the novel cage. Trunk blood was collected in 1.5 ml ethylenediametetraacetic acid-coated 
microcentrifuge tubes (VWR, West Chester, PA) and kept on ice until centrifuged for 15 
minutes at 2000 r.p.m. at -20° C. Plasma was then transferred to clean, 0.5 ml 
microcentrifuge tubes and stored at -80° C. Plasma CORT levels were determined using a 
commercially available radioimmunoassay (RIA) kit (MP Biomedicals, Orangeburg, NY, 
performed at University of Delaware, Newark, DE). Assay standards were run in 
duplicate and samples were run in double duplicate. The CORT intra-assay variability 
was 6.8%. Duplicates that had a coefficient of variation greater than 15% were not used 
 64 
for analysis. In all cases except one, at least one set of duplicates from a sample was 
usable. When both sets were usable, all four values were averaged to create a final mean 
value for that sample. Specific group sizes are noted in the figures. 
 Data were analyzed using ANOVA with genotype and condition as factors. For 
significant main effects or interactions, a Fisher’s PLSD post-hoc was used to determine 
within genotype differences between time-points and a t-test with Bonferroni correction 
(significance = p < 0.01) was used to compare genotypes within a time point. All data are 
expressed as mean±SE. 
 
Stress-induced Hyperthermia 
 Stress-induced hyperthermia is one measure to determine physiological response 
to stress (Koshibu, Ahrens, & Levitt, 2005; Zethof, Van der Heyden, Tolboom, & 
Olivier, 1994). Mice were individually housed for 10 days prior to the experiment. Eight 
Lsamp
+/+
 and 7 Lsamp
-/-
 mice were used. Mice were picked up and rectal temperature 
(T1) was measured for 20 seconds using a Thermalert-5 (PhysiTemp, Clifton NJ). Mice 
were then returned to the home cage for 10 minutes, at which point rectal temperature 
was taken again (T2) for 20 seconds. The change in temperature (T2-T1) was calculated 
(dT). Data were analyzed using a 2-way ANOVA including genotype and stress 
condition as factors. Data are expressed as mean ± SE. 
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Figure 1. Structures quantified for c-Fos activation.
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C-Fos Immunocytochemistry 
 Mice were singly housed for 13-16 days prior to novelty exposure and brain 
collection. Two groups were used for c-Fos measures. Control, non-stressed, mice 
(lsamp
+/+ 
= 12, lsamp
-/- 
= 9) were sacrificed directly after removal from the home-cage. 
Novelty exposed mice (lsamp
+/+ 
= 13, lsamp
-/- 
= 10) were placed in a square arena (27cm 
x 27cm x 27cm) with clear Plexiglas walls and white floors for 10 minutes and then 
returned to their home-cage until time of sacrifice, 2 hours after placement in the novel 
arena. Novelty exposure for all animals was between 8 and 10 am. Mice were deeply 
anesthetized with sodium pentobarbital (60mg/kg i.p.) and perfused transcardially with 
4% paraformaldehyde in phosphate-buffered saline (PBS, 7.2 pH). Brains were removed 
and post-fixed overnight at 4° C, and then cryoprotected in sequential 24-hour 
incubations of 10, 20, and 30% sucrose in PBS. Coronal sections of 50μm were cut on a 
sliding microtome in 4-6 series and collected into freezing medium at -20°C until 
processing. 
 Briefly, free-floating sections were washed several times in PBS, incubated for 10 
min in 0.5% H2O2 in PBS, rinsed again in PBS, incubated for 30min in 0.1 M Tris-
glycine (pH 7.4), and washed several times in Blotto (4% Carnation dried milk in PBS 
with .2% Triton-X 100). Sections were incubated in rabbit anti-c-Fos (Oncogene, 
Cambridge, MA) at 1:20,000 in Blotto for 48-72 hours at 4°C. After several Blotto 
washes for 30 minutes, sections were incubated in biotin-SP-conjugated donkey anti-
rabbit IgG (Jackson Immunoresearch, West Grove, PA) at 1:1000 in Blotto for 1 hour at 
room temperature. After 30 minutes of washing in Blotto sections were processed using 
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the ABC method (Vector, Burlingame, CA) and rinsed in PBS before visualization by 
application of 0.5% 33-diaminobenzidine (DAB) and .05% H2O2 for 4 minutes.  Sections 
were then washed in PBS, mounted onto gelatin-subbed slides, dehydrated with alcohols, 
cleared with xylene and counterstained with Cresyl-violet in order to visualize anatomy. 
Slides were coverslipped using DPX (Fisher, Pittsburg PA). 
 Slides were coded that so that the investigator was blinded to genotype.  C-Fos 
positive nuclei were counted in the following brain areas: ventromedial (VMO) and 
infralimbic (IL) pre-frontal cortex, CA1, CA3, and dentate gyrus (DG) of the 
hippocampus, central (CeA), medial (MeA) and basal lateral (BLA) nuclei of the 
amygdala, locus coeruleus (LC) and the paraventricular nucleus of the hypothalamus 
(PVN). Because not every brain had sections at a representative Bregma level, sample 
size for each analysis is noted below. Specific group sizes are noted in the figures and 
tables. Images were acquired under brightfield illumination with a Zeiss AxoCam HRc 
camera and Axiovision 4.1 software. For all areas counts were c-Fos positive cell counts 
were obtained bilaterally on one section. In VMO cortex (Bregmas: 2.2 – 2.6), positive 
nuclei were counted within a 30.5 μm by 44 μm rectangle, drawn with one long end laid 
against the pial surface (Figure 1a). In IL cortex (Bregmas: 1.4 – 1.8), a box that was 36.6 
μm in the dorsal-ventral direction was defined from the pial surface to the edge of the 
white matter and used for counting (Figure 1b). In CA1 (for all hippocampal areas 
Bregmas: -2.2 – -2.4) positive nuclei were counted within a strip (mean width = 68 μm) 
of the pyramidal layer (Figure 1e). In CA3 positive nuclei were counted within a strip of 
the pyramidal layer (Figure 1e). All positive nuclei within the boundaries of a rectangle 
extending from the dorsal to the ventral surface of the DG on one section were counted 
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(Figure 1e). Within the amygdala (for all amygdalar bregmas: -1.5 -- -1.7) and LC  
(Bregmas: -5.3 -- -5.68) positive nuclei were counted within the anatomical boundaries of 
the nucleus of interest (Figure 1d and 1f). Within PVN (Bregma: -0.6 -- -0.8) positive 
nuclei were counted within the boundaries of the nucleus that was contained in a 
rectangle defined as 1 x 1.5 times the widest width of the PVN on that section (Figure 
1c). The average number of cells in PVN was obtained by counting CV positive nuclei in 
the same area in which c-Fos positive counts were made. The average number of c-Fos 
positive nuclei in each area and the average number of cells in PVN was calculated with 
Abercrombie’s formula (Abercrombie & Johnson, 1946). To measure average profile 
size, the diameter of c-Fos positive nuclei or CV positive nuclei was measured using 
ImageJ (US National Institutes of Health, Bethesda, MD).  
 For all areas except PVN, data were analyzed as number of c-Fos positive nuclei 
per unit area (μm2). For the PVN data were also expressed and analyzed as % increase of 
c-Fos positive nuclei/μm2 over mean wildtype basal c-Fos positive nuclei/μm2. Data were 
analyzed using a 2-way ANOVA including genotype and stress condition as factors.  
Data are expressed as mean± standard error (SE). 
 
CRF and GAD-67 Immunocytochemistry 
 Rabbit anti-CRF (1:10,000, generously donated by AJ Silverman) and mouse anti-
glutamic acid decarboxylase-67 (GAD-67) (1:2000, Chemicon, Temecula, CA) were 
used for staining with selected series of brain sections from the c-Fos experiment. 
Sections were processed as described for c-Fos with the following alterations: anti-CRF 
was blocked with 5% Blotto and processed in DAB for 2 minutes; anti-GAD-67 was 
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blocked in 4% Blotto with no Triton-X 100 added in any steps, secondary antibody was 
biotin-SP-conjugated donkey anti-mouse IgG (Jackson Immunoresearch, West Grove, 
PA) at 1:1000, the ABC Elite kit was used, and DAB processing was 3 minutes. 
 Images were acquired as described for c-Fos staining. For CRF staining 
macroscopic images of the whole brain and 20x images of PVN were obtained. For 
GAD-67 staining, macroscopic images of the whole brain and high magnification images 
of PVN were obtained. Images from the PVN were taken at 63x for approximation of the 
density of GAD-67 in the PVN. A single rectangle was placed on each image and, after 
thresholding, area fraction was determined using ImageJ (US National Institutes of 
Health, Bethesda, MD). The same threshold level was used for each section. Threshold 
level (pixel intensities of 0 – 148) was determined by choosing the mean of the ideal 
threshold for the lightest and darkest image.  
 
Elevated Plus Maze 
 To test for possible pharmacological manipulations that would ameliorate the 
stress response differences in Lsamp
-/-
 mice, we performed pilot studies using elevated 
plus maze (EPM) experiments. Animals were run on the EPM in order to determine if 
there were genotype dependent effects on behavior in the maze. Two drugs were used: 
Antalarmin (Sigma-Aldrich, St. Louis, MO) is a CRF receptor 1 (CRFR1) antagonist 
(Webster et al., 1996) and, Diazepam (Sigma-Aldrich, St. Louis, MO), is a commonly 
used anxiolytic that is a Benzodiazepine receptor (BZR) agonist (McLaughlin et al., 
2003). For the Antalarmin EPM, 4 Lsamp
+/+
 mice were used for each treatment and 6-7 
Lsamp
-/- 
mice were used for each treatment. For the Diazepam EPM, 4-5 Lsamp
+/+
 female 
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mice were used for each treatment and 5 Lsamp
-/- 
female mice were used for each 
treatment.     
 The EPM experiments were performed in the Vanderbilt Kennedy Center and 
Center for Molecular Neuroscience Murine Neurobehavioral Core. Testing took place 
between 12-6 p.m. The apparatus and basic testing procedures were the same as 
described in chapter 2 (p. 37). All the mice in both experiments received an 
interperitoneal injection of either drug or vehicle at a volume of 20ml/kg 30 minutes prior 
to testing. Antalarmin (Sigma-Aldrich, St. Louis, MO), dissolved in a solution of distilled 
water with 0.5% Tween-80, was given at a dose of 10 mg/kg body weight.  Diazepam 
(Sigma-Aldrich, St. Louis, MO), dissolved in a solution of distilled water with 0.5% 
Tween-80, was given at a dose of 1.5mg/kg body weight. 
 EPM data was analyzed as described in chapter 2 (p. 38). For these experiments, 
we measured only the number of entries into the open and closed arms, and duration of 
time spent in the open arms, closed arms and center of the maze. Small n’s were used in 
order to obtain initial observations of the drug effects.  
 
Results 
 
Corticosterone Response to Novel Environments 
 There were no differences in morning basal CORT levels between Lsamp
+/+
 and 
Lsamp
-/-
 mice (Figure 2). In all mice, exposure to a novel environment caused a robust 
increase in peripheral corticosterone levels (Figure 2). In both Lsamp
+/+
 and Lsamp
-/-
 
mice there was a significant increase in CORT levels within 15 minutes after placement 
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Figure 2. CORT response in Lsamp
-/-
 mice to novelty exposure. Lsamp
-/-
 mice have 
normal basal levels of CORT. After exposure to a novel environment, Lsamp
-/-
 mice 
reached peak levels of CORT response within 15 minutes, while Lsamp
+/+
 mice didn’t 
reach peak levels until 30 minutes after exposure to the novel environment. All mice of 
both genotypes had significantly increased CORT levels by 15 minutes and levels 
remained elevated for the entire hour measured (n = 8-12/group) *p = 0.0002 compared 
to littermates at the same timepoint. 
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 in the novel environment (Lsamp
+/+
 p < 0.05 and Lsamp
-/-
, p  < 0.0001) and levels were 
still increased above baseline 60 minutes after novelty exposure (Figure 2).  
 The stress response of the Lsamp
-/-
 mice, however, was distinct from Lsamp
+/+
 
mice. Lsamp
-/-
 mice reached peak CORT levels twice as fast as their wildtype littermates. 
The highest level of CORT observed in Lsamp
-/-
 mice (mean ± SE, 133.72±14.10) was 
15 minutes after exposure to the novel environment, whereas in their wildtype littermates 
peak CORT levels (113.61 ± 17.70) were reached by 30 minutes after placement in the 
novel cage (Figure 2). Lsamp
-/-
 mice had significantly increased levels of CORT 
compared to wildtype littermates at the 15 minute time-point (t(21) = -4.463, p < 0.0002) 
but not at any other time-point measured. 
 
Stress-Induced Hyperthermia 
 There was a normal hyperthermia response to stress in both genotypes.  Thus, 
there were no genotype-dependent effects on T1 or T2 (Figure 3a). And there was no 
difference in dT between Lsamp
+/+
 and Lsamp
-/-
 mice (Figure 3b). 
 
C-Fos Activation 
 We examined activation of neuronal cell groups following a mild stressor by 
evaluating changes in C-Fos protein expression in different forebrain and brain stem 
regions that are well-known to activate in stressful situations (Kovacs, 1998; Martinez, 
Calvo-Torrent, & Herbert, 2002; Singewald, Salchner, & Sharp, 2003).  Basal (home-
cage controls) levels of c-Fos activation (Table 1) between Lsamp
+/+
 and Lsamp
-/-
 mice 
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Figure 3. Stress-induced hyperthermia in Lsamp
-/-
 mice. Lsamp
-/-
 mice did not differ from 
wildtype littermates in either their basal (T1) or stressed (T2) temperature (a). The change 
in temperature (dT) (b) was also no different between genotypes. (n = 7-8/group). 
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were not different in any of the brain areas measured, as there were no main effects of 
genotype or genotype by condition interactions in any area except PVN, where further 
analysis demonstrated no difference in basal levels of activation between genotypes 
(Figure 4). 
 Based on the quantitative analysis of the number of immunoreactive nuclei in 
different brain regions, there was a significant increase in c-Fos protein expression after 
exposure to a novel environment in mice of both genotypes. A main effect of condition 
was found in VMO (F(1,26) = 54.30, p < 0.0001) and IL (F(1,29) = 66.5, p < 0.0001), CA1 
(F(1,30) = 15.84, p < 0.001) and CA3 (F(1,14) = 43.79, p < 0.0001) of the hippocampus, 
BLA (F(1,30) = 56.46, p < 0.0001) and MeA (F(1,30) = 155.85, p < 0.0001) of the amygdala, 
PVN (F(1,40) = 92.05, p < 0.0001) and in LC (F(1,30) = 30.89, p < 0.0001). Exposure to a 
novel environment did not cause a rise in c-Fos protein expression in either hippocampal 
DG (F(1,30) = 0.534, p = 0.48), or  CeA of the amygdala (F(1,30) = .281, p = 0.60). There 
were no differences between Lsamp
+/+
 and Lsamp
-/-
 mice (no effect of genotype, or 
genotype x condition interactions) in the numbers of c-Fos positive cells after exposure to 
a novel environment in any areas measured except the PVN of the hypothalamus. 
 Within the PVN, there was a main effect of genotype (F(1,40) = 8.287, p < 0.01) 
and a genotype x condition interaction (F(1,40) = 5.14, p < 0.05). While there was a trend, 
under basal conditions the number of c-Fos positive cells did not differ statistically 
between Lsamp
+/+
 and Lsamp
-/-
 mice (p = 0.06) (Figure 4). However, after a ten-minute 
exposure to a novel environment, Lsamp
-/-
 mice exhibited significantly larger percent 
change from basal counts (mean diff= 1639.33%, p < 0.05) in c-Fos activation compared 
to their wildtype littermates (Figure 4). 
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Table 1. Basal levels of c-Fos activation did not differ between Lsamp
+/+
 and Lsamp
-/-
 
mice in any areas measured. Data presented are the mean number of c-Fos positive 
nuclei/μm2(10-4) ± SE. 
 
 
Area Lsamp
+/+
 Lsamp
-/-
 
VMO 42.67±4.54 46.74±12.09 
IL 20.32±8.98 16.60±3.84 
CA1 5.87±0.89 5.62±1.10 
CA3 0.65±0.19 0.58±0.20 
DG 1.29±0.29 1.50±0.15 
CeA 1.55±0.40 1.93±0.35 
MeA 0.40±0.07 0.49±0.10 
BLA 0.35±0.09 0.39±0.10 
PVN 1.09±0.14 0.77±0.00 
LC 0.76±0.22 0.50±0.26 
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Figure 4. C-Fos activation in the PVN of Lsamp
-/-
 mice. Basal levels of c-Fos protein 
expression were normal in Lsamp
-/-
 PVN. Lsamp
-/-
 mice had an exaggerated increase in c-
Fos activation after exposure to a novel environment, nearly double the increase of 
Lsamp
+/+
 mice. (n = 9-11/group) *p < 0.05 compared to littermates in same group.  
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CRH and GAD-57 Immunocytochemistry 
 Because of the key role that CRH plays in mediating the central stress response, 
we used immunocytochemistry to examine possible differences in the expression or 
organization of CRH-positive neurons and processes. The entire forebrain was examined, 
and we found no gross differences in CRH staining throughout these regions between 
Lsamp
+/+
 and Lsamp
-/-
 mice (Figure 5a) or within the PVN at higher power (Figure 5b). 
The PVN of both genotypes was characterized by moderate fiber staining, along with a 
few cell bodies. As expected from previous studies of CRF immunoreactivity, dense 
staining was observed in CeA and BNST where there are CRF-producing cell bodies 
(Asan et al., 2005) (Gray, 1990). 
 Because there is a large GABAergic inhibitory drive to the PVN, we used 
immunocytochemistry for GAD-67 to examine if GABAergic input to the PVN is altered. 
GAD-67 staining appeared to be decreased throughout the PVN of Lsamp
-/-
 mice (Figure 
6a). Using area fractionation we determined that there was a non-significant trend for a 
decreased density of GAD-67 in the PVN of Lsamp
-/-
 mice, with a 73% decrease in 
GAD-67 staining (Figure 6b). 
 
Elevated Plus Maze 
While the neuroanatomical data failed to detect differences in CRH expression between 
genotypes, physiological alterations might account for changes in stress responsiveness in 
the Lsamp
-/- 
mice. Antalarmin is a well-characterized CRH-R1 receptor antagonist that 
we hypothesized would reduce the response to novelty normally exhibited by the mutant 
mice. There was no main effect of treatment with Antalarmin or a genotype x treatment 
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Figure 5. Lsamp
-/-
 mice appear to have normal CRF distribution. Lsamp
-/-
 mice did not 
appear to differ from their wildtype littermates in either amount or distribution of CRF in 
limbic areas of the brain. 
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interaction on either maze entries or duration spent in different areas of the maze. As 
expected from our previous studies, there was a main effect of genotype (F(1,21) = 14.27, p 
< 0.01), with Lsamp
-/-
 mice making significantly more open entries (t(19) = 3.96, p < 
0.001) than Lsamp
+/+
 mice.  
 The differential response to novelty between genotypes may also reflect 
differences in GABAergic modulation of stress-response circuitry. Diazepam is a well-
known anxiolytic that reduces anxiety-like behavior on the EPM. Administration of low 
dose (1.5mg/kg) diazepam resulted in several novel alterations in behavior. There were 
main effects of treatment (F(1,19) = 7.19, p < 0.05) and a treatment x genotype interaction 
(F(1,19) = 4.96, p < 0.05) on number of entries. These effects were accounted for by 
significant decreases in both open (t(8) = 4.52, p < 0.002) and closed (t(8) = 8.4, p < 
0.0001) entries by Diazepam-treated Lsamp
-/-
 mice (Figure 7a) as compared to vehicle 
treated Lsamp
-/-
 mice. Lsamp
+/+
 mice entries were not affected by drug treatment (Figure 
7a). 
 There was no main effect of genotype or treatment on time spent within each arm 
(durations). There was a three-way interaction between treatment, genotype and category 
of duration (F(2,19) = 3.64, p < 0.05). Diazepam treated Lsamp
-/-
 mice spent significantly 
more time on the open arms (t(8) = -3.76, p = 0.0056), with a corresponding decrease in 
center time (t(8) = 5.13, p = 0.009) compared to vehicle treated Lsamp
-/-
 mice (Figure 
7b). Drug treatment did not affect the durations that Lsamp
+/+
 mice spent in any portion 
of the maze (Figure 7b). 
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Figure 6. Lsamp
-/-
 mice have alterations in the density of GAD-67 in the PVN. There 
appears to be a decrease in density of GAD-67 positive fibers in the the PVN of Lsamp
-/-
 
mice (a). There is a non-significant trend for decreased density of GAD-67 fibers in the 
PVN as measured by area fractionation (b).  
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Discussion 
 In a novel environment, Lsamp
-/-
 mice are hyperactive and exhibit increased 
exploratory behaviors that also are atypical in their nature (Catania et al., 2008). Some of 
these behaviors (increased entries and duration on the open arms of the EPM) are 
generally interpreted as decreased anxiety, though in the Lsamp
-/-
 mice, increased 
unprotected head dips and an overall increase in activity accompanied the unusual 
exploratory behavior. Because of this combination of atypical behaviors, we 
hypothesized that in Lsamp
-/-
 mice, the phenotype was driven by heightened emotional 
reactivity to stressful environments, indicated by hyper-activation and/or lack of 
appropriate inhibition when placed in a novel situation. Multiple studies indicate that in 
general, animals that display decreased anxiety have a correspondingly blunted HPA axis 
response to stress (Kalinichev, Easterling, & Holtzman, 2002; Meaney, 2001; Timpl et 
al., 1998). If Lsamp
-/-
 mice are more reactive to novel environments and not simply less 
anxious, we hypothesized that Lsamp
-/-
 mice would also demonstrate a more sensitive, or 
reactive, neuroendocrine stress response in these environments, accompanied by changes 
in brain function that would be permissive of both the altered behavioral and 
physiological responses. 
 We found that the HPA axis of Lsamp
-/-
 mice does display heightened reactivity 
in response to a novel environment. Although the absolute peak level of CORT response 
was normal, Lsamp
-/-
 mice mounted a CORT response much more quickly than wildtype 
mice. This resulted in an alteration in the kinetics of the stress response.  Increased HPA 
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Figure 7. Effect of Diazepam on Lsamp
-/-
 mice behavior in the EPM.  A dose of 1.5mg/kg 
Diazepam had no effect on the anxiety or motor behavior of female Lsamp
+/+
 mice. 
However, Lsamp
-/-
 mice had greatly reduced motor activity as measured by decreased 
entries (a) into all parts of the maze. They also had a corresponding increase the duration 
of time spent in the open arms (b), probably because they spent much of the test not 
moving in the open arm. (n = 4-5/group). * p < 0.005 compared to vehicle treated mice. 
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responsiveness is frequently seen in conjunction with increases in anxiety behaviors 
(Meaney, 2001; Mitra & Sapolsky, 2008). There is thus a mismatch that we find between 
exploratory behavior on the EPM, an indicator of reduced stress, and more rapid HPA 
response, an indicator of increased stress. This lends support to the hypothesis that the 
absence of LAMP via constitutive deletion of the Lsamp gene, leads to a heightened and 
maladaptive response to novel environmental stressors and that the behavioral phenotype 
is caused more by hyper-reactivity to the stressful environment than to decreased anxiety. 
Several recent human genetic studies demonstrate a role for LAMP in human disorders of 
emotional regulation. Polymorphisms in the Lsamp gene have been associated both with 
panic disorder and male suicide (Koido et al., 2006; Maron et al., 2006; Must et al., 
2008), highlighting the importance of discovering LAMPs role in defining and/or 
modulating the circuitry that underlies emotional regulation.   
  There are many potential loci along the HPA axis at which stress-induced CORT 
release can be altered (Miller & O'Callaghan, 2002; Rosenfeld et al., 1992) ranging from 
alterations in the brain circuitry responsible for exciting the PVN, to changes in pituitary 
or adrenal sensitivity or response. However, SIH, a gross measure of the peripheral 
physiological stress response (Veening et al., 2004; Zethof et al., 1994) was normal in 
Lsamp
-/-
 mice, suggesting that at least some parts of the peripheral physiological stress 
response are intact. Given that it is an alteration in the speed of the CORT response as 
opposed to an alteration in absolute level, it seems possible that the increased sensitivity 
of HPA axis is due to a permissive state in the brain, created by either decreased 
inhibitory tone, or increased excitatory drive. This possibility is supported by the 
heightened behavioral reactivity to novelty observed in Lsamp
-/-
 mice because there is 
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overlap in the brain circuitry that regulates the behavioral response to novelty and the 
stress response (Lopez, Akil, & Watson, 1999) and LAMP is normally heavily expressed 
in the limbic structures (Cote et al., 1996; Pimenta, Reinoso et al., 1996; Reinoso et al., 
1996) responsible for regulating these responses. Disruption of this circuitry could 
potentially underlie both phenotypes. 
 Exaggerated c-Fos induction in the PVN of Lsamp
-/-
 mice after exposure to a 
novel environment also suggests that regulation of the peripheral stress response may be 
altered at the level of limbic circuitry. The PVN is the first direct responder 
(parvocellular PVN neurons release CRF), and only CNS structure, of the HPA axis 
cascade (Miller & O'Callaghan, 2002). Basal levels of the number of c-Fos-positive PVN 
neurons were not statistically different between wild type and Lsamp
-/-
 mice, though we 
do note that there was a trend towards a very modest difference in basal activation state. 
The very robust changes seen after the mild stressor suggest that the Lsamp
-/-
 mice are not 
in a pathological state of a heightened activation under normal conditions, but there is a 
dramatic state change during exposure to a novel environment. It has been demonstrated 
that as CORT increases in response to stimulus intensity, c-Fos induction within the PVN 
also increases (Campeau & Watson, 1997). Given this, it seems likely that the activity 
within the PVN may be responsible for the increased CORT response exhibited by 
Lsamp
-/-
 mice. 
 Release of CRF from the PVN is mediated either directly or indirectly by many of 
the brain structures involved in mediating the behavioral response to stress, including the 
other structures that we examined in the c-Fos experiment. It is important to note that 
while c-Fos induction is an excellent way to measure gross changes in brain activation in 
 85 
response to stress, it has limitations (Kovacs, 1998; Martinez et al., 2002). For example, 
most of the areas we measured have neurons of several types (e.g. excitatory and 
inhibitory cells), and it is possible that subtle changes in activation of a certain cell type 
could alter the function of downstream circuitry but would be missed by assaying for c-
Fos induction in the entire nucleus. Therefore, it is possible and even likely, given that 
the other areas we examined have either direct or indirect projections to the PVN, that 
there are alterations in signaling in other parts of the stress pathway, but that the 
differences are too specific or subtle to perceive using c-Fos induction as a marker. 
 CRF released from the PVN and other brain structures, such as CEA, is also 
involved in modulating anxiety and stress related behaviors (Muller et al., 2000). One 
possible mechanism for both a sensitized CORT response and increased behavioral 
reactivity would be an increased total amount of CRF or CRFR1, the receptor primarily 
responsible for mediating both the neuroendocrine and anxiety related functions of CRF 
(Bale, 2005). However, immunocytochemistry did not reveal any gross alterations in 
either levels or distribution of the CRF protein in Lsamp
-/-
 mice. Moreover, Lsamp
-/-
 mice 
displayed no alterations in sensitivity to Antalarmin, an antagonist to the CRFR1 
receptor, on the EPM. This is not definitive evidence that there is no alteration in CRF 
signaling in Lsamp
-/-
 mice, but it does suggest that there may be a more robust alteration 
in the anatomy or signaling of the stress related brain circuitry that may underlie the 
phenotype of Lsamp
-/-
 mice.  
  Inhibitory regulation of the PVN by GABAergic cells comes from peri-PVN, 
other hypothalamic areas and the BNST (Herman et al., 2003; Herman, Mueller, & 
Figueiredo, 2004). GABAergic neurons provide tonic inhibiton to the HPA axis under 
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basal conditions and also regulate stress reactivity. Stress-induced c-Fos activation in the 
PVN is reduced by stimulation of GABA-A receptors, indicating that GABAergic 
inhibition can reduce HPA axis reactivity to stress (Kovacs, Miklos, & Bali, 2004). There 
appeared to be a decrease in GABAergic fibers in the parvocellular region of the PVN of 
Lsamp
-/-
 mice, indicating that there may be decreased GABAergic tone to the PVN. A 
decreased inhibitory drive on the PVN could create a cellular environment that was more 
permissive to excitatory input and explain why Lsamp
-/-
 mice have greater stress induced 
c-Fos activation and mount a much faster CORT response. 
 Lsamp
-/-
 mice also exhibited a high level of motoric depression on the EPM when 
administered a low dose of Diazepam. This dose had no motor or open/closed arm 
exploratory effects on Lsamp
+/+
 mice. Generally, Diazepam does not have sedative 
effects until much higher doses (McKernan et al., 2000; Zeller et al., 2008), suggesting 
that Lsamp
-/-
 mice have extremely heightened sensitivity to the drug. This increased 
sensitivity could result from upregulation of BZRs in Lsamp
-/-
 mice in order to 
compensate for decreased GABAergic tone throughout the brain. GABAergic signaling is 
also critical in the expression of anxiety related behaviors and increases levels of BZRs in 
GABAergic circuitry have been demonstrated to underlie decreased anxiety-like 
behaviors and HPA axis responsiveness in both mouse and rat models (Caldji, Diorio, 
Anisman, & Meaney, 2004; Caldji et al., 2003; Caldji et al., 2000). Therefore, it is 
possible that alterations in GABAergic tone may underlie both the behavioral deficits and 
the heightened HPA axis reactivity seen in Lsamp
-/-
 mice response to novel environments. 
To investigate this possibility, the Diazepam experiment will be replicated with a larger 
cohort of animals and radioligand binding will be performed to determine both total 
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GABAR and BZR levels in order to examine what alterations in the GABAR system 
exist in Lsamp
-/-
 mice. To further address the hypothesis that deletion of Lsamp may alter 
GABAergic tone, further experiments to elucidate both the integrity and functionality of 
GABAergic signaling are necessary. 
 The present data demonstrate that constitutive deletion of the Lsamp gene leads to 
increased reactivity to novel environments, both through heightened HPA axis sensitivity 
and increased hyper-activation of circuitry regulating the stress response. Combined with 
our previous data, this establishes a definitive role for LAMP in modulating the 
development and functioning of the circuitry that mediates emotional regulation. 
Identifying the specific circuitry alterations that underlie the behavioral and 
neuroendocrine phenotypes of Lsamp
-/-
 mice will better elucidate the role of the LAMP 
protein in the modulation of stress and behavior. 
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CHAPTER IV 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 We have demonstrated that the genetic deletion of Lsamp increases the 
behavioral, physiological and neurobiological responses to the stress of novelty exposure. 
Lsamp
-/-
 mice are markedly more hyperactive than their littermates when exposed to 
novel environments, but when allowed to acclimate, they return to normal levels of 
motoric output. During the period when the hyperactive response is at its peak, Lsamp
-/-
 
mice display disruptions in normal exploratory behaviors. These include anxiety-related 
behavioral changes such as increased proportion of entries into the open arms and 
increased time in the open arms of the EPM. Increased exploratory behavior in the 
unprotected areas of the maze was accompanied by increased head-dips in the same 
portions of the maze and by decreased spontaneous alternation in the y-maze. In concert, 
these behaviors suggest that Lsamp
-/-
 mice experience hyper-activation or lack of 
appropriate inhibition when exposed to the stress of a novel environment. This is 
mirrored in the neuroendocrine response to novelty. Although Lsamp
-/-
 mice have normal 
basal levels of CORT, the HPA axis response to exposure to a novel environment is 
augmented, with Lsamp
-/-
 mice reaching peak CORT levels twice as quickly as wildtype 
littermates. Finally, hyper-reactivity to novelty stress is reflected in the brain, with 
Lsamp
-/-
 mice demonstrating greater than normal activation of the PVN, the first structure 
of the HPA axis, after placement in a novel environment. Taken together, these data 
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demonstrate that genetic deletion of Lsamp
-/-
 causes disrupted emotional regulation that is 
reflected in brain function, physiological response and behavior. 
 The next step to understanding how LAMP is involved in emotional regulation 
will be to examine what changes in brain circuitry underlie the phenotypes of increased 
behavioral, endocrine, and neural activity in Lsamp
-/-
 mice. Our preliminary data suggest 
that Lsamp
-/-
 mice have decreased GABAergic tone in the PVN, such that the increased 
stress activation of the PVN and its downstream effects on the HPA axis may be due to 
decreased inhibitory drive to the nucleus. If deletion of LAMP somehow results in 
decreased GABAergic tone throughout limbic circuitry, it could explain the behavioral, 
neuroendocrine and neural activity changes we see in Lsamp
-/-
 mice. The PVN is under 
strong inhibitory drive from several limbic brain structures that counteract excitatory 
drive in times of stress (Herman et al., 2003; Wall et al., 2004). Disruption of this 
inhibition by decreased GABA input to the PVN could explain why the HPA axis 
response can be elicited much more quickly in Lsamp
-/-
 mice. Less inhibition would 
permit the acceleration of excitation, also arising from disparate brain areas (Herman et 
al., 2003), to reach a threshold more quickly. Combined with the pilot study 
demonstrating that Lsamp
-/-
 mice have heightened motor sensitivity to a BZR agonist, it 
is possible that GABAergic tone is altered throughout the brain by both changes in 
GABA levels and in either numbers or types of GABA receptors. In order to explore this 
possibility further we will first need to replicate the sensitized motor depression seen in 
Lsamp
-/-
 mice in response to Diazepam in a larger cohort of male mice. We also will need 
to expand on the PVN findings, both by demonstrating that there is significantly less 
GAD-67 in the PVN and also by expanding our consideration to the GABA receptors, 
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using radioligand binding to probe both the total number of GABA receptors and the 
number of BZRs. Determining what alterations in limbic GABAergic function are cause 
by genetic deletion of LAMP will inform the next steps in understanding how LAMP 
effects limbic circuit function. 
 LAMP is expressed from very early in development throughout the life of the 
animal and it is therefore not possible to determine if the disrupted stress response we 
observed in the Lsamp
-/-
 mice, which carry a constitutive deletion of the gene, is due to 
differential development of the limbic circuitry that mediates these behaviors, or if the 
lack of LAMP in the adult animal has a direct effect on circuit function. There are many 
examples of developmental perturbations during the critical period of limbic circuit 
formation causing long-term alterations in stress induced behavior, endocrine response 
and/or neural microciruitry (Leonardo & Hen, 2008; Levine, 2005; Meaney, 2001; 
Moriceau & Sullivan, 2004). Alternatively, other CAM’s are known to play a role in 
adult plasticity, such as LTP (reviewed by Rougon & Hobert, 2003) and it is possible that 
LAMP plays a similar role. Whether the effect is developmental, results from absence of 
LAMP in the adult brain, or is due to a combination of both, cannot be definitively 
determined in a constitutive knockout animal. 
 However, because LAMP’s role modulating the development of the circuitry of 
emotional regulation has been established in vitro, examining Lsamp
-/-
 mice for 
alterations of behavior, endocrine function, and limbic circuit formation during 
development may help to shed light on its role in vivo. It would be interesting to examine 
Lsamp
-/-
 mice for behavioral alterations at several stages of development in order to 
determine if there is a consistent alteration in stress responsive behaviors. For example, it 
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has been demonstrated that mice with reduced levels of TGF have normal anxiety-
related behavior until puberty (Koshibu et al., 2005), so the behavioral paradigms which 
we have already used could be repeated in pre-pubertal Lsamp
-/-
 mice to determine if the 
stress related disruptions are already present. Stress responsive behavior could also be 
tested early postnatally by examining ultra-sonic vocalizations induced by separating the 
pup from the dam. In rodents this behavioral response to stress is predictive of adult 
anxiety-like behavior (Brunelli & Hofer, 2007). The development of the HPA axis 
response could also be examined early postnatally. The SHRP occurs in the mouse from 
post-natal day (pnd) 1 to pnd 12 (Schmidt, Enthoven et al., 2003). During the SHRP 
stressors that would normally activate the HPA axis do not, but this suppression of stress 
response can be lifted by a 24-hour separation from the dam (Levine et al., 1988; Stanton 
et al., 1988). Employing this paradigm of would reveal whether Lsamp
-/-
 mice undergo a 
normal SHRP and if the brain is functionally able to respond to stressors once inhibition 
by the dam is lifted. There also is an overlap in the period during which the SHRP occurs 
in the mouse and the timing of the formation of the telencephalic circuits that regulate 
HPA axis responsiveness. Structures like the amygdala (pnd 4 - 6.5), the BNST (pnd 8 – 
10.5) and the pre-frontal cortex (pnd 8 – 10.5) come “on-line” during the SHRP 
(Rinaman, Levitt, & Card, 2000) and are in place to regulate HPA axis reactivity as the 
SHRP ends and pups become responsive to environmental challenges. Card et. al. have 
demonstrated that handling and separation from the dam during the SHRP, the same 
paradigms used to alter adult behavioral and endocrine stress responsiveness, either delay 
or decrease the input from these limbic circuits into the PVN (Card et al., 2005). If the 
formation of these circuits also is altered in Lsamp
-/-
 mice, it would demonstrate an in 
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vivo role of LAMP in forming the circuits of emotional regulation and suggest that the 
alterations that we see in the adult mice may be at least partially due to developmental 
alterations of the underlying circuitry. Given the purported role of LAMP in constructing 
limbic circuitry, it seems likely that Lsamp
-/-
 mice would show disruptions of stress 
related behavior, endocrine response, and circuit formation early postnatally, as this is 
when LAMP would be guiding circuit formation and when the critical developmental 
periods of stress response behavior and physiology are being established. 
 Another way to determine how LAMP mediates its role in emotional regulation 
would be to create a conditional knockout mouse in which Lsamp expression can be 
temporally regulated. The effectiveness of determining when a molecule is important in 
regulating stress responsiveness using this method has been demonstrated with a 
conditional deletion of the serotonin 1A receptor (Gross et al., 2002). Gross et. al. 
determined that eliminating expression of the receptor for only the first two weeks of life 
was sufficient to induce anxiety-like behaviors in the adult, and that deleting the receptor 
only during adulthood had no effect on anxiety-like behaviors. Using temporally 
controlled gene deletion would create the opportunity to discriminate between the 
developmental and adult effects of genetically deleting Lsamp and aid in the 
understanding the role of LAMP during development and in the modulation of adult 
circuits. 
 There is also an intriguing possibility that LAMP may be involved in human 
disorders of emotional regulation. There are human genetic studies that implicate Lsamp 
polymorphisms in both panic disorder and male suicide (Koido et al., 2006; Maron et al., 
2006; Must et al., 2008). Human anxiety disorders have been proposed to involve 
 93 
abnormal exaggeration of defensive behaviors such as hypervigilence and increased 
escape responses (Rodgers, 1997) which would mimic the alterations we observed in 
Lsamp
-/-
 mice. Of course, genetic deletion of a gene is not the same as modulating the 
levels or function of a molecule and it is possible that more subtle changes in LAMP may 
have differential effects. Investigating the functional effects of Lsamp polymorphisms is 
an important next step for understanding their role in human disease. It will be useful to 
know if these changes are associated with increases or decreases in Lsamp expression to 
better understand the role of LAMP in both normal and disrupted human anxiety states. 
 Lsamp
-/-
 mice provide a valuable tool for better understanding how limbic 
networks regulate stress response and for examining the role of LAMP in emotional 
regulation. Although the mechanism of LAMP’s role in the circuitry of emotional 
regulation is still unclear, further studies should determine the subtle circuit changes 
resulting when LAMP is absent, elucidate its function in the normal development and 
maintenance of stress responsiveness, and may provide insight into how LAMP may be 
altered in neuropsychological disease. 
 Studies of Lsamp
-/-
 mice also are an example of the importance of careful use of 
rodent behavioral tasks. The tests that are commonly used to determine the phenotypes of 
mice with genetic mutations are not based on the animal’s ethology but were developed 
to test pharmaceuticals for use in humans. This makes them very useful for screening 
novel drugs but the measures used to predict drug effectiveness do not automatically 
translate to measures of a human psychiatric state in an animal.  When we genetically 
modify an animal and use behavioral tasks to determine how the molecule may be 
involved in normal behavior, we are trying to understand their behavioral state, not their 
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reactivity to drugs for human neuropsychiatric disease. So, for example, in Lsamp
-/-
 mice 
increased open arm time and increased proportion of open arm entries on the EPM would 
typically be interpreted as reduced anxiety because that effect is typical of anxiolytics in 
rodents. However, our subsequent experiments to determine the effects of deleting Lsamp 
on emotional regulation showed that Lsamp
-/-
 mice are more reactive to stress, not less as 
a state of decreased “anxiety” would suggest. Behavioral tests of rodent “anxiety” are 
useful for examining the behavioral response to stress and can be informative of 
emotional reactivity. But, we must interpret the results based on the actual behaviors of 
the animal (which include motoric activation and inhibition), taking into account all of 
the behaviors that they display and what those behaviors mean in an ethological 
framework. This is currently rarely done and there is need both for more careful 
interpretation of rodent behavioral tests and the development of new methods of 
measuring stress responsiveness (e.g. Blanchard, Griebel, & Blanchard, 2001) if we want 
to correctly determine the role of specific molecules in the development or maintenance 
of emotional regulation. 
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